syndrome	score	normalized_score
DRAVET SYNDROME	2.6698290399999998	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52074085	56.96023330392721
MYOCLONIC-ASTASTIC EPILEPSY	1.2235454940000001	45.82860833665965
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.71050326128747
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1564266	43.31463111211047
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.47586096374171
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.45558180009908
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.45558180009908
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.00002232352675
LAFORA DISEASE	0.77152896	28.898066072425376
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.863911825605136
CRANIOSYNOSTOSIS 4; CRS4	0.75406504	28.243944788314984
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.038460619935424
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.545853812422386
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.6884104739999999	25.78481482095198
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59705175	22.36292066101731
ROLANDIC EPILEPSY	0.5906213	22.122064415030863
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.808658220303126
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	19.976297808192246
MENINGIOMA	0.5277778	19.768224560176336
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.74010290936082
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.358807483793047
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5135696	19.236048162844167
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.99156247098129
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.500545554	18.748224942522913
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.500545554	18.748224942522913
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.72779090004954
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.72779090004954
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.5	18.72779090004954
CREST SYNDROME	0.5	18.72779090004954
PAROXYSMAL HEMICRANIA	0.5	18.72779090004954
TRICHODENTOOSSEOUS SYNDROME	0.5	18.72779090004954
INHALATIONAL ANTHRAX	0.5	18.72779090004954
TRICHO-DENTO-OSSEOUS SYNDROME	0.5	18.72779090004954
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42505119	15.920539616274459
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415131304	15.5489845147538
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.315261534498855
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981	14.54661718714394
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.65480353004176
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.39103195911001
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.39103195911001
CENTRALOPATHIC EPILEPSY	0.3547009	13.285528574518764
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.34968319400000003	13.097587476986918
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.348573844	13.056036127316977
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.915707142057306
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.831992418510813
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.748953019104176
COG4-CDG	0.333878554	12.5056154906458
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.485181448172428
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.485181448172428
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.485181448172428
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31997624999999996	11.984896605963954
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.284670646926516
DOORS SYNDROME	0.290935564	10.89716081595996
DYSTONIA 6, TORSION	0.2635135	9.87005145468041
PALLISTER-HALL SYNDROME	0.261290384	9.7867833514913
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.259940294	9.736214945058807
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.253270354	9.486388461787051
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.252506059	9.457761347895145
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.252176874	9.44543153220028
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	9.437482184252518
NIJMEGEN BREAKAGE SYNDROME	0.25	9.36389545002477
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.36389545002477
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.25	9.36389545002477
HYPERPARATHYROIDISM 2	0.25	9.36389545002477
HYPEREKPLEXIA 1; HKPX1	0.25	9.36389545002477
OTOFACIOCERVICAL SYNDROME 2	0.25	9.36389545002477
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.25	9.36389545002477
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.10339764676468
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.23908618	8.955111972263213
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	8.787633982736214
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.711093726061202
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.462307758851855
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.216847064	8.122132943763322
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21135259	7.916334223407803
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.805869097895497
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20518830000000002	7.6854471550732715
6P22 MICRODELETION SYNDROME	0.20163132	7.552218399721955
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.491116360019817
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.491116360019817
JUVENILE HYALINE FIBROMATOSIS	0.2	7.491116360019817
BETA-THALASSEMIA	0.2	7.491116360019817
INFANTILE MYOFIBROMATOSIS	0.2	7.491116360019817
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175	7.093778184388916
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18559615399999999	6.951611927930785
MYOCLONIC EPILEPSY OF INFANCY	0.18559615399999999	6.951611927930785
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.853446316547669
AURICULOOSTEODYSPLASIA	0.17473152	6.54467074041565
AURICULOOSTEODYSPLASIA	0.17473152	6.54467074041565
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.17143447299999998	6.421177926808378
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.3835381010014025
MICROTRIPLICATION 11Q24.1	0.1693918	6.344668421166025
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.169261734	6.3397967234636114
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.168466454	6.310009048369629
UNILATERAL POLYMICROGYRIA	0.1680017	6.292601416905706
BRANCHIOSKELETOGENITAL SYNDROME	0.167208419	6.262888615519742
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.974378793932064
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.974378793932064
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15945894999999996	5.972627745482908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.801751785575004
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.718037062028511
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.718037062028511
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.67794782844972
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.15155264999999998	5.6764926790967865
LÉRI-WEILL DYSCHONDROSTEOSIS	0.14959561999999998	5.603190981846538
DISTAL MONOSOMY 7Q36	0.14612321899999997	5.473130182148291
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14520145	5.438604787967997
PIEBALDISM	0.14482163999999997	5.424378783444501
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.371226091690126
PACMAN DYSPLASIA	0.14285699999999998	5.350792049216754
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.350792049216754
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.14285699999999998	5.350792049216754
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	5.350792049216754
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.350792049216754
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.152640934642017
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.123509855896991
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.962066784620787
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12522615399999998	4.690418454658804
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.12406020000000001	4.646746969236653
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12231927000000001	4.581539423213407
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.425498720322556
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.2360502603567465
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.11157119400000001	4.178963983401725
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.111069204	4.1601616558938925
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.10689451999999999	4.003796437842327
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10576764	3.961588491823432
BILATERAL POLYMICROGYRIA	0.104660764	3.9201298072628656
AICARDI SYNDROME; AIC	0.1036867	3.8836456734323335
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.10044303400000001	3.7621522762371336
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310399999999	3.7063460812457114
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.6853990471240063
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.675210979052052
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.675210979052052
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.675210979052052
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.675210979052052
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.675210979052052
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.09720319399999999	3.6408021840979
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.09636237	3.609308631986414
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08992909	3.3683463867034726
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.08122672000000002	3.042394055313745
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.96059443566469
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.077789744	2.9136601196007668
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.901633506840574
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.901633506840574
TURNPENNY-FRY SYNDROME; TPFS	0.077216954	2.8922059369014885
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.881199464367202
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.858201737141941
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07628449400000001	2.857280105096168
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07573894	2.8368460626227967
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07485825	2.803859306287267
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07300403999999999	2.7344087919577054
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.695833812639929
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.6792052572774474
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.6753997701665577
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.071273159	2.6695776370759683
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6510836064619325
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07073174	2.6492984734333405
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.5737932643057926
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.5737932643057926
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.5174740776660367
ATELOSTEOGENESIS TYPE II	0.06683839999999999	2.5034711585877423
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.4970400351926654
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.4970400351926654
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.4970400351926654
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.4970400351926654
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.4970400351926654
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.4970400351926654
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.4970400351926654
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.4970400351926654
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.4970400351926654
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.4970400351926654
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.06609343300000001	2.475567986180869
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.065901773	2.468389249373061
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4276760432570623
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4276760432570623
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.06403056399999998	2.398302027608479
HOLMES-GANG SYNDROME	0.063504124	2.3785839111256353
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.344638891185333
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.061868669	2.317326992592754
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.061868669	2.317326992592754
611961 STEVENSON-CAREY SYNDROME	0.061783093	2.314121693724629
PENILE AGENESIS	0.06132725	2.2970478289501264
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.060411494	2.2627476551831953
49,XXXYY SYNDROME	0.0602926	2.2582944112406538
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.05874582	2.2003588664238967
WHITE-SUTTON SYNDROME; WHSUS	0.058150334000000005	2.178054591840083
15Q13.3 MICRODELETION SYNDROME	0.058074693	2.1752214141771415
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1641052342437628
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.057314533	2.1467491791159787
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.05694194	2.1327934915263342
2P15P16.1 MICRODELETION SYNDROME	0.056773114	2.1264700154733505
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.056773114	2.1264700154733505
2Q23.1 MICRODUPLICATION SYNDROME	0.055901954	2.093840210832376
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.080867320253585
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.080867320253585
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.080867320253585
GITELMAN SYNDROME	0.055555600000000004	2.080867320253585
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.080867320253585
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.080867320253585
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.080867320253585
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.080867320253585
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.080867320253585
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.080867320253585
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.080867320253585
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.055222199	2.06837959182585
MOWAT-WILSON SYNDROME; MOWS	0.055137659000000006	2.06521309694047
BAKER-GORDON SYNDROME; BAGOS	0.054808473999999996	2.0528832812456037
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.054804339	2.05272840241486
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.05426292	2.032449238772233
POTOCKI-LUPSKI SYNDROME	0.053718573	2.012060405186094
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.053177154	1.9917812415434661
KEPPEN-LUBINSKY SYNDROME	0.053173019	1.9916263627127229
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.053173019	1.9916263627127229
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05286995	1.9802747369921485
THREE M SYNDROME 2; 3M2	0.0526316	1.9713471990700948
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.0526316	1.9713471990700948
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.0526316	1.9713471990700948
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.0526316	1.9713471990700948
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0526316	1.9713471990700948
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0526316	1.9713471990700948
CHROMOSOME 1P36 DELETION SYNDROME	0.05187993299999999	1.9431930742651593
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214000000006	1.9207677057853867
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9170185893251055
AICARDI SYNDROME	0.05084891999999999	1.904575882506694
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.83820211948852
ADNP SYNDROME	0.048677239	1.8232343071674735
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0475633	1.7815110738326527
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.045921984	1.720034628134841
DISTAL MONOSOMY 12Q	0.044937054	1.6831435019524696
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.682711114716169
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.659205639624026
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.043986594000000004	1.6475434696747477
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.043266764	1.6205818182275824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6199072431993624
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.6014714560150265
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.6014714560150265
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.5994732007259909
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.042599213999999996	1.5955783445969258
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.04236914	1.5869607890698503
PITT-HOPKINS-LIKE SYNDROME	0.042317719	1.585034785598107
WITTEVEEN-KOLK SYNDROME	0.042292453	1.5840884328683458
COG2-CDG	0.04221225399999999	1.5810845326635594
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041904994	1.5695759305996613
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.04134734	1.548688675586509
CANAVAN DISEASE	0.04134734	1.548688675586509
CHRISTIANSON SYNDROME	0.04134734	1.548688675586509
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.5458350846314866
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.04126499	1.5456042084252708
AARSKOG-SCOTT SYNDROME	0.040165494	1.504421946058389
ALPERS-HUTTENLOCHER SYNDROME	0.039675944000000005	1.4860855659881507
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.03961994	1.4839879035850176
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4720174741975238
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4709593540116714
TRICHOTHIODYSTROPHY	0.039213874	1.4687784653057787
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038925143999999995	1.4579639151726358
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03857885999999999	1.4449936464845703
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4428377031961566
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.038470234000000006	1.4409249964559532
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.03837959	1.4375298726992647
HELSMOORTEL-VAN DER AA SYNDROME	0.038366653	1.4370453098375169
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4189395437844214
LISSENCEPHALY 2; LIS2	0.037582554	1.407676425603641
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.407676425603641
16P13.11 MICRODELETION SYNDROME	0.037582554	1.407676425603641
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3872423831302698
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3872423831302698
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.3872423831302698
MCLEOD SYNDROME; MCLDS	0.037037	1.3872423831302698
MYOCLONUS AND ATAXIA	0.037037	1.3872423831302698
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3872423831302698
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.036868693999999994	1.380938383979822
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036765933	1.3770894109384624
WEST SYNDROME	0.03656844	1.3696921957220154
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.036484994	1.3665666772431242
LUSCAN-LUMISH SYNDROME; LLS	0.036402013	1.3634585756097701
THUMBS, CONGENITAL CLASPED	0.0361093	1.3524948398943177
WOLF-HIRSCHHORN SYNDROME	0.035932933	1.3458889112989798
15Q24 MICRODELETION SYNDROME	0.035932933	1.3458889112989798
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.035842320000000004	1.3424949486653275
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3359001443777838
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3359001443777838
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3359001443777838
TEMPLE-BARAITSER SYNDROME	0.035387379	1.3254548688256085
RAMOS-ARROYO SYNDROME	0.03531504	1.3227453694937712
15Q26 OVERGROWTH SYNDROME	0.03526382	1.3208268945939703
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3042052310585404
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3042052310585404
TRISOMY 17P	0.034520354	1.2929799430153777
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.034520354	1.2929799430153777
PEHO SYNDROME	0.03443497399999999	1.2897819854412849
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2760835802430255
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.033889419999999996	1.2693479429679138
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.033844734	1.2676742028395946
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.033760194	1.2645077079542144
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.033426874	1.2520230134286052
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.03329918	1.2472401603662233
NOONAN SYNDROME 4; NS4	0.03288132	1.231588970955234
OROFACIAL CLEFT 15	0.03288132	1.231588970955234
3P25.3 MICRODELETION SYNDROME	0.03285823	1.2307241215714697
SLC35A2-CDG	0.032803653999999995	1.2286799457391473
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.228525066908404
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.228525066908404
TUBEROUS SCLEROSIS-1	0.032799519	1.228525066908404
PIERPONT SYNDROME	0.032336973	1.2112001373690955
WIEACKER-WOLFF SYNDROME	0.032336973	1.2112001373690955
ALG13-CDG	0.0322581	1.2082459032657762
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2082459032657762
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03208814	1.2018799525830315
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.031795554	1.1909209737264674
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.031795554	1.1909209737264674
XP22.13P22.2 DUPLICATION SYNDROME	0.031791419	1.1907660948957244
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.03125	1.1704869312530963
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.03125	1.1704869312530963
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.03125	1.1704869312530963
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.169622081869332
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.1128417795620351
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.02907618	1.089065238424405
CHROMOSOME 17Q12 DELETION SYNDROME	0.028658319999999998	1.0734140490134154
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0721285734460362
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0721285734460362
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341364	1.0615422776283834
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	1.0615422776283834
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0608677026001636
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0608677026001636
8Q24.3 MICRODELETION SYNDROME	0.028232942999999996	1.0574813059940347
GANGLIOCYTOMA	0.027777800000000002	1.0404336601267925
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0404336601267925
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0404336601267925
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0404336601267925
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0327460517846492
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0325911729539057
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.027535599	1.0313618807592266
AYMÉ-GRIPP SYNDROME	0.027495253999999997	1.0298507353115014
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.027442293999999996	1.027867087699368
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0123120093112778
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	1.0123120093112778
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0123120093112778
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0123120093112778
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0123120093112778
CONGENITAL TRACHEAL STENOSIS	0.02593705	0.9714872979282598
DISTAL MONOSOMY 10Q	0.025924793	0.9710282048621361
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.025664603999999997	0.9612826744891501
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.025609454	0.9592169991528747
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9262845534109556
19P13.3 MICRODUPLICATION SYNDROME	0.023939994	0.8966864035608813
PENTASOMY X	0.023825814	0.8924097252309461
HAREL-YOON SYNDROME; HAYOS	0.023535474	0.8815348716111051
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.023392444	0.8761775997462369
SALT-AND-PEPPER SYNDROME	0.023392444	0.8761775997462369
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.022989919999999997	0.8611008291377339
AMISH INFANTILE EPILEPSY SYNDROME	0.022846889999999998	0.8557435572728657
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.022601589999999998	0.8465557030573013
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8432451540043179
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8432451540043179
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8432451540043179
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8432451540043179
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.022402593000000002	0.8391021546458272
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.022209149999999997	0.8318566345356705
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8228111115309467
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.02157802	0.8082172931941741
ZUNICH NEUROECTODERMAL SYNDROME	0.021453519	0.8035540358044799
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7972946462519562
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.021164049999999997	0.7927118059963869
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.021101304	0.790361618060758
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.021096879000000002	0.7901958771112926
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.021045054	0.7882547415845025
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.020910783000000002	0.7832255431606214
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.7802949060738361
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.776860603778585
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.776860603778585
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.776860603778585
X SMALL RINGS	0.020639574	0.7730672522761983
GAUCHER DISEASE	0.02061185	0.7720288337263723
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.767810211548227
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.020443214	0.7657124742339309
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.020369364	0.7629463795179935
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.020150623000000003	0.7547533080994582
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.020088734	0.7524352195974318
FG SYNDROME TYPE 1	0.020016633	0.7497346346940627
BAND HETEROTOPIA; BH	0.019954873	0.7474213779620886
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	0.7474213779620886
CORNELIA DE LANGE SYNDROME	0.019734099000000005	0.7391521593457537
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.019704193999999998	0.7380320501720214
16P13.2 MICRODELETION SYNDROME	0.019677793	0.7370431853569172
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7269873354887174
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7269873354887174
HHHH SYNDROME	0.019409319	0.7269873354887174
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.7225398971613555
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.019275884	0.7219894499312212
OKAMOTO SYNDROME	0.019270364	0.7217826951196846
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.719373402275975
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7147313072899979
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.018933593999999998	0.7091687788368651
NON-DISTAL MONOSOMY 20Q	0.018932908999999998	0.709143121763332
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.018910813	0.7083155032278771
TOE, MISSHAPEN	0.0188679	0.7067081718460895
TRACHEOBRONCHOMEGALY	0.0188679	0.7067081718460895
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7067081718460895
MONOPHALANGY OF GREAT TOE	0.0188679	0.7067081718460895
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7067081718460895
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7067081718460895
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7067081718460895
RAYNAUD DISEASE	0.0188679	0.7067081718460895
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7067081718460895
THROMBOCYTOPENIA 3	0.0188679	0.7067081718460895
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7067081718460895
CARPAL DISPLACEMENT	0.0188679	0.7067081718460895
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7067081718460895
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7067081718460895
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7067081718460895
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.7067081718460895
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7067081718460895
KNUCKLE PADS	0.0188679	0.7067081718460895
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7067081718460895
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.7067081718460895
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7067081718460895
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7067081718460895
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7067081718460895
LETTERER-SIWE DISEASE	0.0188679	0.7067081718460895
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7067081718460895
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7067081718460895
SPINAL ARACHNOIDITIS	0.0188679	0.7067081718460895
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7067081718460895
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7067081718460895
VAN DEN BOSCH SYNDROME	0.0188679	0.7067081718460895
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7067081718460895
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7067081718460895
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7067081718460895
VESICOURETERAL REFLUX 1	0.0188679	0.7067081718460895
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7067081718460895
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7067081718460895
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7067081718460895
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7067081718460895
PUBIC BONE DYSPLASIA	0.0188679	0.7067081718460895
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7067081718460895
NEPHROSIALIDOSIS	0.0188679	0.7067081718460895
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01859082	0.6963299792409181
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6942972648166267
AL KAISSI SYNDROME; ALKAS	0.018196432999999998	0.6815579847015223
EMANUEL SYNDROME	0.018185983000000003	0.6811665738717114
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018008939999999998	0.6745353253030762
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.017981513999999997	0.6735080685166267
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.017954909999999998	0.6725116002184169
6Q25 MICRODELETION SYNDROME	0.017934033	0.6717296400371763
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.017644564	0.6608874102290835
PEDIATRIC-ONSET GRAVES DISEASE	0.017644564	0.6608874102290835
1P36 DELETION SYNDROME	0.017521433000000003	0.6562754669864556
RUBINSTEIN-TAYBI SYNDROME	0.017521433000000003	0.6562754669864556
SAETHRE-CHOTZEN SYNDROME	0.017473019	0.6544620924491855
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.017365939	0.650451348750031
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.017309632999999998	0.6483423747611944
CRANIOFRONTONASAL DYSPLASIA	0.01726492	0.6466676233321667
CERVICAL RIB	0.0172414	0.6457866680482284
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6457866680482284
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6457866680482284
MOSAIC TRISOMY 15	0.0172414	0.6457866680482284
ERYTHERMALGIA, PRIMARY	0.0172414	0.6457866680482284
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6457866680482284
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6457866680482284
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6457866680482284
CARDIAC ARRHYTHMIA	0.0172414	0.6457866680482284
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6457866680482284
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6457866680482284
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6457866680482284
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6457866680482284
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6457866680482284
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6457866680482284
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6457866680482284
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6457866680482284
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6457866680482284
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6457866680482284
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6457866680482284
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6457866680482284
TRANSSEXUALITY	0.0172414	0.6457866680482284
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6457866680482284
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6457866680482284
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6457866680482284
SICKLE CELL ANEMIA	0.0172414	0.6457866680482284
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6457866680482284
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6457866680482284
PALMOMENTAL REFLEX	0.0172414	0.6457866680482284
ALCOHOL DEPENDENCE	0.0172414	0.6457866680482284
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6457866680482284
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6457866680482284
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6457866680482284
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6457866680482284
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6457866680482284
DIASTEMATOMYELIA	0.0172414	0.6457866680482284
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6457866680482284
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6457866680482284
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6457866680482284
MOTION SICKNESS	0.0172414	0.6457866680482284
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6457866680482284
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6457866680482284
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6457866680482284
RHEUMATOID ARTHRITIS	0.0172414	0.6457866680482284
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6457866680482284
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6457866680482284
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6457866680482284
269800 SENILE PLAQUE FORMATION	0.0172414	0.6457866680482284
MYOPATHY, CONGENITAL	0.0172414	0.6457866680482284
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6457866680482284
DESMOSTEROLOSIS	0.017190659999999996	0.6438861718276911
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.017102273999999997	0.6405756227747077
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.017099009999999998	0.6404533677557122
CONGENITAL ANALBUMINEMIA	0.017099009999999998	0.6404533677557122
INDOMETHACIN EMBRYOFETOPATHY	0.017099009999999998	0.6404533677557122
RENAL TUBULAR DYSGENESIS	0.017099009999999998	0.6404533677557122
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.016931599999999998	0.6341829288065576
SUMMITT SYNDROME	0.016931599999999998	0.6341829288065576
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.016931599999999998	0.6341829288065576
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.016898068999999998	0.6329270056932185
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016891613	0.6326851924571171
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6310165837435046
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6310165837435046
RING CHROMOSOME 7 SYNDROME	0.016847059999999997	0.6310164339211771
CUTIS LAXA	0.016768213999999997	0.6280632111185666
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.016764078999999998	0.6279083322878232
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.016716994	0.6261447362187655
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.016555979999999998	0.6201138631708044
CORNELIA DE LANGE SYNDROME 3	0.016387253	0.6137940952204191
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.016350194	0.6124060288144892
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.016350194	0.6124060288144892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.016350194	0.6124060288144892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.016350194	0.6124060288144892
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6105825412701331
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6105825412701331
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6105825412701331
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6105825412701331
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6105825412701331
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016293334	0.6102763044333356
NEUROFACIODIGITORENAL SYNDROME	0.016222659999999996	0.6076291686451952
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.016125574000000004	0.6039927560305511
3MC SYNDROME 2	0.016023693999999998	0.6001767813567568
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.015969393	0.5981429058094296
AICARDI-GOUTIÈRES SYNDROME	0.015923613	0.5964281892746212
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.015845834	0.5935149315777912
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.015845834	0.5935149315777912
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01580464	0.5919719863411179
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01580464	0.5919719863411179
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01580464	0.5919719863411179
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01580464	0.5919719863411179
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.0157379	0.5894722008117793
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.015678313	0.5872403350590569
6Q TERMINAL DELETION SYNDROME	0.015678313	0.5872403350590569
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01566324	0.5866757670745839
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01566324	0.5866757670745839
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.015635813999999998	0.5856485102881344
PERLMAN SYNDROME	0.015635813999999998	0.5856485102881344
DUANE RETRACTION SYNDROME	0.015627092999999998	0.5853218601592557
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.015557828999999999	0.5827275367414537
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.57947358307257
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.57947358307257
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.57947358307257
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.57947358307257
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.57947358307257
MUCOPOLYSACCHARIDOSIS TYPE 2	0.015426473000000001	0.57780752133852
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.015423838999999998	0.5777088633360584
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.015378058999999998	0.5759941468012498
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.015293772999999998	0.5728371656336467
SILVER-RUSSELL SYNDROME	0.0151932	0.5690701454052655
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.015181173000000001	0.5686196671229556
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.015181173000000001	0.5686196671229556
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.015178728999999998	0.5685281256810361
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.015136893999999998	0.5669611714164289
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.015135473	0.5669079470346912
MALAN OVERGROWTH SYNDROME	0.015132758999999997	0.5668062925856855
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01510677	0.5658328594702828
TETRASOMY X	0.015015374000000001	0.562409569116081
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5590395405991988
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5590395405991988
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5590395405991988
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5590395405991988
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.014808660000000001	0.5546669759798554
PFEIFFER SYNDROME	0.014803140000000001	0.5544602211683187
COFFIN-SIRIS SYNDROME 6; CSS6	0.014752353999999999	0.5525580019910189
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.014724120000000002	0.551500481094475
VELO-FACIAL-SKELETAL SYNDROME	0.01472412	0.5515004810944749
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.014667814	0.5493915071056386
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.014656573	0.5489704689106236
SPINOCEREBELLAR ATAXIA TYPE 13	0.014600473	0.5468692107716381
FAMILIAL LAMBDOID SYNOSTOSIS	0.014591339999999998	0.5465271289430577
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.014591339999999998	0.5465271289430577
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.014591339999999998	0.5465271289430577
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.014591339999999998	0.5465271289430577
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.014591339999999998	0.5465271289430577
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.014392009999999998	0.5390611078228439
HAMAMY SYNDROME; HMMS	0.014339500000000002	0.5370943152225208
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.5335230753202085
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5335230753202085
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5335230753202085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5335230753202085
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5335230753202085
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.5335230753202085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014240018999999998	0.5333681964894651
TRISOMY 20P	0.014206799999999999	0.5321239595176476
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.014059054	0.5265900471290103
ZEBRA BODY MYOPATHY	0.014059054	0.5265900471290103
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.014059054	0.5265900471290103
OGDEN SYNDROME	0.014059054	0.5265900471290103
CITRULLINEMIA TYPE I	0.014054918999999999	0.5264351682982668
KUFOR-RAKEB SYNDROME	0.014054918999999999	0.5264351682982668
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.014054918999999999	0.5264351682982668
RAPID-ONSET DYSTONIA-PARKINSONISM	0.014054918999999999	0.5264351682982668
QAZI-MARKOUIZOS SYNDROME	0.014054918999999999	0.5264351682982668
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014004494	0.5245464705859968
ROBERTS SYNDROME	0.013722894000000001	0.5139989787510889
ROIFMAN SYNDROME; RFMN	0.013722894000000001	0.5139989787510889
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013698599999999998	0.5130890328468373
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5130890328468373
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5130890328468373
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5130890328468373
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5130890328468373
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5130890328468373
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5130890328468373
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5130890328468373
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5130890328468373
RING CHROMOSOME 14 SYNDROME	0.013671174	0.5120617760603877
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671174	0.5120617760603877
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.013671173999999998	0.5120617760603877
WRINKLY SKIN SYNDROME	0.013671173999999998	0.5120617760603877
PEHO-LIKE SYNDROME; PEHOL	0.013671173999999998	0.5120617760603877
MUENKE SYNDROME	0.013662452999999998	0.511735125931509
FANCONI ANEMIA	0.013597324	0.5092956813444505
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.013577912999999999	0.5085686310461287
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.013577912999999999	0.5085686310461287
CARNOSINASE DEFICIENCY	0.013569600000000001	0.5082572627946246
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.013555373	0.5077243822323546
SPASMUS NUTANS	0.0135135	0.5061560046556389
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.0135135	0.5061560046556389
BETHLEM MYOPATHY	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT17 TYPE	0.0135135	0.5061560046556389
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0135135	0.5061560046556389
DYSTONIA 26, MYOCLONIC; DYT26	0.0135135	0.5061560046556389
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0135135	0.5061560046556389
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0135135	0.5061560046556389
OROMANDIBULAR DYSTONIA	0.0135135	0.5061560046556389
DYSTONIA 11, MYOCLONIC	0.0135135	0.5061560046556389
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0135135	0.5061560046556389
SPINOCEREBELLAR ATAXIA TYPE 35	0.0135135	0.5061560046556389
DYSTONIA 21; DYT21	0.0135135	0.5061560046556389
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.0135135	0.5061560046556389
MYOCLONUS-DYSTONIA SYNDROME	0.0135135	0.5061560046556389
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.0135135	0.5061560046556389
ACERULOPLASMINEMIA	0.0135135	0.5061560046556389
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.0135135	0.5061560046556389
FAMILIAL PAROXYSMAL ATAXIA	0.0135135	0.5061560046556389
SPRENGEL DEFORMITY	0.0135135	0.5061560046556389
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.0135135	0.5061560046556389
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	0.0135135	0.5061560046556389
SANDIFER SYNDROME	0.0135135	0.5061560046556389
DYSTONIA 16	0.0135135	0.5061560046556389
DYSTONIA 7, TORSION	0.0135135	0.5061560046556389
BETHLEM MYOPATHY 1	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT21 TYPE	0.0135135	0.5061560046556389
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.0135135	0.5061560046556389
AUTOSOMAL DOMINANT FOCAL DYSTONIA, DYT25 TYPE	0.0135135	0.5061560046556389
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT4 TYPE	0.0135135	0.5061560046556389
DYSTONIA 13, TORSION	0.0135135	0.5061560046556389
TORTICOLLIS	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT2 TYPE	0.0135135	0.5061560046556389
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0135135	0.5061560046556389
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0135135	0.5061560046556389
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0135135	0.5061560046556389
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT6 TYPE	0.0135135	0.5061560046556389
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0135135	0.5061560046556389
DYSTONIA 12; DYT12	0.0135135	0.5061560046556389
DYSTONIA 23; DYT23	0.0135135	0.5061560046556389
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.0135135	0.5061560046556389
PRIMARY DYSTONIA, DYT13 TYPE	0.0135135	0.5061560046556389
DYSTONIA 25	0.0135135	0.5061560046556389
SPINOCEREBELLAR ATAXIA TYPE 17	0.0135135	0.5061560046556389
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.0135135	0.5061560046556389
ACERULOPLASMINEMIA	0.0135135	0.5061560046556389
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0135135	0.5061560046556389
TRISOMY X	0.013507613000000002	0.5059355036455818
48,XXYY SYNDROME	0.013507613000000002	0.5059355036455818
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.013507613000000002	0.5059355036455818
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.013461833000000001	0.5042207871107732
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.013384054	0.5013075294139433
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.013379919	0.5011526505831999
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.013305034	0.49834778934009955
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.013302108999999998	0.4982382317633341
MIETENS SYNDROME	0.013299514000000002	0.498141034528563
PELIZAEUS-MERZBACHER DISEASE	0.013255119000000001	0.4964781939745476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.013244592999999999	0.4960839365205197
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.013244592999999999	0.4960839365205197
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.013244592999999999	0.4960839365205197
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.013244592999999999	0.4960839365205197
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.013216533	0.49503293289520894
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.013177340000000001	0.4935649362777177
RAINE SYNDROME	0.013121033999999998	0.4914559622888812
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.013121033999999998	0.4914559622888812
JACOBSEN SYNDROME	0.013086293	0.49015471792156406
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013032358999999999	0.48813458857275743
ACROCALLOSAL SYNDROME; ACLS	0.012976399	0.4860385742152239
MUCOPOLYSACCHARIDOSIS TYPE 3	0.012916279000000001	0.483786744637402
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.012837164	0.48082344628328716
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.012760689999999998	0.4779590681207063
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.012703174	0.47580477287789186
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.012670979	0.47459889042183767
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4712389000008779
FIBROCHONDROGENESIS	0.012575479999999998	0.47102191981551
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.012575479999999998	0.47102191981551
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.012540739	0.4697206754481928
ZELLWEGER SYNDROME	0.012540739	0.4697206754481928
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.012490939999999999	0.46785542493012966
FACIOCARDIORENAL SYNDROME	0.012490939999999999	0.46785542493012966
FACIOCARDIORENAL SYNDROME	0.012490939999999999	0.46785542493012966
TEMPLE SYNDROME	0.012468400000000001	0.46701117611635545
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.012420640000000002	0.4652222975295828
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.012215133000000001	0.45752491328058975
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01215762	0.45537073040452064
FRANK-TER HAAR SYNDROME; FTHS	0.012129560000000001	0.4543197267792099
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.01207834	0.4524012518794088
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45095973635825015
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45095973635825015
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45095973635825015
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45095973635825015
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45095973635825015
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45095973635825015
FUMARASE DEFICIENCY; FMRD	0.012039854	0.45095973635825015
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.45095973635825015
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012039854	0.45095973635825015
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.45095973635825015
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.45095973635825015
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45095973635825015
CLASSICAL EHLERS-DANLOS SYNDROME	0.01199932	0.4494415118055649
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.011876293000000001	0.4448334639434442
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.011876293	0.44483346394344414
ROIFMAN-CHITAYAT SYNDROME	0.011769454	0.4408317470395034
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.011652843999999999	0.43646405164579377
PELGER-HUET ANOMALY; PHA	0.011652843999999999	0.43646405164579377
W SYNDROME	0.011652843999999999	0.43646405164579377
KLEEFSTRA SYNDROME 2; KLEFS2	0.011613272999999999	0.43498189681838206
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.011613272999999999	0.43498189681838206
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.011613272999999999	0.43498189681838206
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.011613272999999999	0.43498189681838206
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.011613272999999999	0.43498189681838206
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.011613272999999999	0.43498189681838206
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.011613272999999999	0.43498189681838206
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.011511533	0.43117116592604
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4305256938848789
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4305256938848789
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4305256938848789
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4305256938848789
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4305256938848789
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4305256938848789
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4305256938848789
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.011472773	0.4297193875754682
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.011472773	0.4297193875754682
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011454973	0.42905267821942644
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.011420449999999999	0.4277595991689415
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.011420449999999999	0.4277595991689415
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.011413943	0.42751587569816835
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011413943	0.42751587569816835
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.011413943	0.42751587569816835
MELAS	0.01135259	0.42521786338798684
ARTERIAL TORTUOSITY SYNDROME	0.011334874000000002	0.4245543003008164
2Q23.1 MICRODELETION SYNDROME	0.011330739000000001	0.4243994214700729
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.011290383999999999	0.4228879014665298
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.011286248999999998	0.42273302263578644
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0112239	0.4203977045661321
COG5-CDG	0.011201708999999999	0.4195665277504061
TEMPLE SYNDROME	0.011128160000000002	0.4168117071645907
INFANTILE SIALIC ACID STORAGE DISEASE	0.011121653	0.41656798369381737
ISOLATED PLAGIOCEPHALY	0.011071853999999999	0.4147027331757542
CRANIOSYNOSTOSIS 6; CRS6	0.011071853999999999	0.4147027331757542
BRESEK SYNDROME	0.011071853999999999	0.4147027331757542
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.011071853999999999	0.4147027331757542
LINEAR NEVUS SEBACEUS SYNDROME	0.011067718999999998	0.4145478543450108
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.011067718999999998	0.4145478543450108
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011067718999999998	0.4145478543450108
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.011067718999999998	0.4145478543450108
CINCA SYNDROME	0.010998094	0.4119400094621789
ADAMS-OLIVER SYNDROME	0.010993959	0.41178513063143546
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.010970114	0.4108920022834121
PALLISTER-KILLIAN SYNDROME	0.010927219	0.4092853451020969
XQ12-Q13.3 DUPLICATION SYNDROME	0.01089058	0.4079130100405231
TRISOMY 18	0.010872524	0.40723671205554046
DIAPHANOSPONDYLODYSOSTOSIS	0.010872524	0.40723671205554046
20Q13.33 MICRODELETION SYNDROME	0.010868389	0.4070818332247971
HYPERTELORISM, TEEBI TYPE	0.01080366	0.4046573708704585
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.010789320000000002	0.4041202578274451
SECKEL SYNDROME	0.010789320000000002	0.4041202578274451
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.010782813	0.4038765343566718
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.010782813	0.4038765343566718
KOOLEN-DE VRIES SYNDROME; KDVS	0.010782813	0.4038765343566718
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.010782813	0.4038765343566718
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.010744829999999999	0.40245385899315855
CAMPOMELIA, CUMMING TYPE	0.010744829999999999	0.40245385899315855
DOWN SYNDROME	0.01071564	0.40136053056041376
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.01066029	0.3992873641077782
FREEMAN-SHELDON SYNDROME	0.01066029	0.3992873641077782
MECKEL SYNDROME 12; MKS12	0.01066029	0.3992873641077782
MARINESCO-SJÖGREN SYNDROME	0.010659254	0.3992485601250334
OCCIPITAL HORN SYNDROME	0.010659254	0.3992485601250334
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.010655119000000001	0.39909368129429
THANATOPHORIC DYSPLASIA	0.010655119	0.3990936812942899
WILLIAMS SYNDROME	0.010631100000000001	0.3981940356750334
COSTELLO SYNDROME; CSTLO	0.010580234	0.39628882005118954
CARDIOFACIOCUTANEOUS SYNDROME	0.010580234	0.39628882005118954
VASCULAR EHLERS-DANLOS SYNDROME	0.010580234	0.39628882005118954
HEREDITARY OROTIC ACIDURIA	0.010574714	0.39608206523965306
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.010574714	0.39608206523965306
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.010526299999999999	0.3942686907023829
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.010526299999999999	0.3942686907023829
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.010526299999999999	0.3942686907023829
ROBINOW-SORAUF SYNDROME	0.010526299999999999	0.3942686907023829
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.010526299999999999	0.3942686907023829
ATELOSTEOGENESIS, TYPE I; AO1	0.01045254	0.3915059669888077
CORNEODERMATOOSSEOUS SYNDROME	0.01045254	0.3915059669888077
KNIEST-LIKE DYSPLASIA, LETHAL	0.01045254	0.3915059669888077
CORNEODERMATOOSSEOUS SYNDROME	0.01045254	0.3915059669888077
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.01045254	0.3915059669888077
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.010368	0.38833947210342734
RENAL AGENESIS, BILATERAL	0.01032697	0.3868026695821692
ACRORENAL-MANDIBULAR SYNDROME	0.01032697	0.3868026695821692
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.01032697	0.3868026695821692
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.0101137	0.3788145176516621
MULTIPLE EPIPHYSEAL DYSPLASIA	0.0101137	0.3788145176516621
GMS SYNDROME	0.01003468	0.3758547775778183
ACITRETIN/ETRETINATE EMBRYOPATHY	0.01003468	0.3758547775778183
DIAMOND-BLACKFAN ANEMIA 1	0.01003468	0.3758547775778183
PETERS-PLUS SYNDROME; PTRPLS	0.009925993	0.37178384275871085
FILIPPI SYNDROME	0.009841453	0.3686173478733305
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3672450128117567
KRABBE DISEASE	0.009804814	0.3672450128117567
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3672450128117567
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.3672450128117567
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.3672450128117567
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3672450128117567
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3672450128117567
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3672450128117567
BIOTINIDASE DEFICIENCY	0.009804814	0.3672450128117567
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3672450128117567
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.3672450128117567
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3672450128117567
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.3672450128117567
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36709013398101326
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36709013398101326
17Q12 MICRODELETION SYNDROME	0.009782622999999999	0.36641383599603067
ADAMS-OLIVER SYNDROME 2; AOS2	0.009782622999999999	0.36641383599603067
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.009782622999999999	0.36641383599603067
OLIVER SYNDROME	0.00976705	0.3658305402206577
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00971018	0.36370044128368617
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00971018	0.36370044128368617
METAPHYSEAL ACROSCYPHODYSPLASIA	0.009710179999999999	0.36370044128368606
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00969584	0.3631633282406727
MOSAIC MONOSOMY X	0.00969584	0.3631633282406727
TURNER SYNDROME	0.00969584	0.3631633282406727
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00969584	0.3631633282406727
MONOSOMY X	0.00969584	0.3631633282406727
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00969584	0.3631633282406727
OROFACIODIGITAL SYNDROME TYPE 2	0.009552444	0.35779234763286566
CONGENITAL TOXOPLASMOSIS	0.009490333	0.35546594399167974
KAGAMI-OGATA SYNDROME	0.009490333	0.35546594399167974
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.35546594399167974
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.35546594399167974
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.009490333	0.35546594399167974
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.009490333	0.35546594399167974
GALLOWAY-MOWAT SYNDROME	0.009490333	0.35546594399167974
KAGAMI-OGATA SYNDROME	0.009490333	0.35546594399167974
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.35546594399167974
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009462353	0.354417936812913
PETERS PLUS SYNDROME	0.009384574	0.351504679116083
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.009300034	0.3483381842307027
8P INVERTED DUPLICATION/DELETION SYNDROME	0.009295899	0.3481833053999593
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.009295899	0.3481833053999593
GAUCHER DISEASE TYPE 3	0.00925926	0.3468109703383854
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3468109703383854
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3468109703383854
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3468109703383854
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3468109703383854
HYDROXYLYSINURIA	0.00925926	0.3468109703383854
GLYCINE ENCEPHALOPATHY	0.00925926	0.3468109703383854
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3468109703383854
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3468109703383854
CARNOSINEMIA	0.00925926	0.3468109703383854
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3468109703383854
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3468109703383854
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3468109703383854
MERRF	0.00925926	0.3468109703383854
PAINE SYNDROME	0.00925926	0.3468109703383854
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3468109703383854
GAUCHER DISEASE TYPE 2	0.00925926	0.3468109703383854
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3468109703383854
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.3468109703383854
OROFACIODIGITAL SYNDROME TYPE 4	0.009241204	0.34613467235340284
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.009241204	0.34613467235340284
MOSAIC TRISOMY 9	0.009241204	0.34613467235340284
EVEN-PLUS SYNDROME	0.009241204	0.34613467235340284
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.009241204	0.34613467235340284
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.009237068999999999	0.3459797935226594
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.009237068999999999	0.3459797935226594
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.009237068999999999	0.3459797935226594
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.009237068999999999	0.3459797935226594
HADDAD SYNDROME	0.009237068999999999	0.3459797935226594
1Q44 MICRODELETION SYNDROME	0.009219123999999999	0.34530765310725664
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.009151493	0.34277449465453413
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.009151493	0.34277449465453413
1Q21.1 MICRODUPLICATION SYNDROME	0.009151493	0.34277449465453413
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009151493	0.34277449465453413
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.009151493	0.34277449465453413
PRADER-WILLI SYNDROME; PWS	0.009151493	0.34277449465453413
TYSHCHENKO SYNDROME	0.008948914	0.3351867803490519
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.3351867803490519
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.3351867803490519
MICROFORM HOLOPROSENCEPHALY	0.008944779	0.3350319015183085
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.3350319015183085
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.3350319015183085
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.008916799	0.3339838943395417
DYSOSTEOSCLEROSIS	0.008916799	0.3339838943395417
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.008916799	0.3339838943395417
OROFACIODIGITAL SYNDROME TYPE 1	0.008911359	0.3337801359745492
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.008832513	0.3308269131719386
SIALURIA	0.008747973000000001	0.32766041828655823
SERKAL SYNDROME	0.00869565	0.32570062988003157
STÜVE-WIEDEMANN SYNDROME	0.00869565	0.32570062988003157
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00869565	0.32570062988003157
TRANSALDOLASE DEFICIENCY	0.00869565	0.32570062988003157
MECKEL SYNDROME, TYPE 1; MKS1	0.00869565	0.32570062988003157
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00869565	0.32570062988003157
HOLZGREVE SYNDROME	0.00869565	0.32570062988003157
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.00869565	0.32570062988003157
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00869565	0.32570062988003157
TERMINAL TRANSVERSE LIMB DEFECT	0.00869565	0.32570062988003157
POSTERIOR URETHRAL VALVE	0.00869565	0.32570062988003157
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00869565	0.32570062988003157
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.00869565	0.32570062988003157
RENAL AGENESIS	0.00869565	0.32570062988003157
THOMAS SYNDROME	0.00869565	0.32570062988003157
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00869565	0.32570062988003157
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00869565	0.32570062988003157
MECKEL SYNDROME	0.00869565	0.32570062988003157
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00869565	0.32570062988003157
ABSENT RADIUS-ANOGENITAL ANOMALIES SYNDROME	0.00869565	0.32570062988003157
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00869565	0.32570062988003157
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.00869565	0.32570062988003157
ULBRIGHT-HODES SYNDROME	0.00869565	0.32570062988003157
HEMOCHROMATOSIS, NEONATAL	0.00869565	0.32570062988003157
HB BART'S HYDROPS FETALIS	0.00869565	0.32570062988003157
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00869565	0.32570062988003157
FONTAINE PROGEROID SYNDROME; FPS	0.00869565	0.32570062988003157
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.32570062988003157
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00869565	0.32570062988003157
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00869565	0.32570062988003157
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.32570062988003157
ACRO-RENAL-MANDIBULAR SYNDROME	0.00869565	0.32570062988003157
PRUNE BELLY SYNDROME	0.00869565	0.32570062988003157
46,XX DISORDER OF SEX DEVELOPMENT-ANORECTAL ANOMALIES SYNDROME	0.00869565	0.32570062988003157
ALPHA-MANNOSIDOSIS	0.008610074	0.3224953310119063
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.008610074	0.3224953310119063
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.008610074	0.3224953310119063
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.008610074	0.3224953310119063
AU-KLINE SYNDROME; AUKS	0.008610074	0.3224953310119063
PRADER-WILLI SYNDROME	0.008605939	0.3223404521811629
16Q24.3 MICRODELETION SYNDROME	0.008605939	0.3223404521811629
SECKEL SYNDROME 7; SCKL7	0.008605939	0.3223404521811629
9Q21.13 MICRODELETION SYNDROME	0.008605939	0.3223404521811629
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.31475273787568064
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.31475273787568064
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.31475273787568064
HYDROLETHALUS	0.00840336	0.31475273787568064
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.31475273787568064
BECKWITH-WIEDEMANN SYNDROME	0.00840336	0.31475273787568064
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.31475273787568064
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.31475273787568064
OMPHALOCELE	0.00840336	0.31475273787568064
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.31475273787568064
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.31475273787568064
SCHISIS ASSOCIATION	0.00840336	0.31475273787568064
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.31475273787568064
FATCO SYNDROME	0.00840336	0.31475273787568064
HEC SYNDROME	0.00840336	0.31475273787568064
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.31475273787568064
RETINOPATHY OF PREMATURITY	0.00840336	0.31475273787568064
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.31475273787568064
PEMPHIGOID GESTATIONIS	0.00840336	0.31475273787568064
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.31475273787568064
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.31475273787568064
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.31475273787568064
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.31475273787568064
VACTERL/VATER ASSOCIATION	0.00840336	0.31475273787568064
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.31475273787568064
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.31475273787568064
YUNIS-VARON SYNDROME	0.00840336	0.31475273787568064
NEMALINE MYOPATHY 10	0.00840336	0.31475273787568064
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.31475273787568064
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31475273787568064
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.31475273787568064
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.31475273787568064
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.31475273787568064
DISTAL MONOSOMY 17Q	0.00840336	0.31475273787568064
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.31475273787568064
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.31475273787568064
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.31475273787568064
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.31475273787568064
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.31475273787568064
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.31475273787568064
EBSTEIN MALFORMATION	0.00840336	0.31475273787568064
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.31475273787568064
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.31475273787568064
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.31475273787568064
MONOSOMY 13Q14	0.008369940000000001	0.31350097233192137
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.008369940000000001	0.31350097233192137
NON-DISTAL MONOSOMY 10Q	0.00836994	0.3135009723319213
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.008291093999999999	0.31054774952931063
OGDEN SYNDROME; OGDNS	0.008206554	0.3073812546439303
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.008206554	0.3073812546439303
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.008206554	0.3073812546439303
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.008206554	0.3073812546439303
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.008206554	0.3073812546439303
OPITZ G/BBB SYNDROME	0.008206554	0.3073812546439303
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.008202418999999999	0.3072263758131869
SHORT SYNDROME	0.00807886	0.3025984015815485
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00806452	0.3020612885385351
CRANIOECTODERMAL DYSPLASIA 4	0.00806452	0.3020612885385351
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00806452	0.3020612885385351
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00806452	0.3020612885385351
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.3020612885385351
FEMORAL-FACIAL SYNDROME	0.00806452	0.3020612885385351
13Q12.3 MICRODELETION SYNDROME	0.00806452	0.3020612885385351
CLASSIC MULTIMINICORE MYOPATHY	0.00806452	0.3020612885385351
CAT-EYE SYNDROME	0.00806452	0.3020612885385351
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00806452	0.3020612885385351
TIBIAL HEMIMELIA	0.00806452	0.3020612885385351
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00806452	0.3020612885385351
COXOPODOPATELLAR SYNDROME	0.00806452	0.3020612885385351
DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2	0.00806452	0.3020612885385351
SCHWARTZ-JAMPEL SYNDROME	0.00806452	0.3020612885385351
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00806452	0.3020612885385351
DIASTROPHIC DWARFISM	0.00806452	0.3020612885385351
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00806452	0.3020612885385351
SPONASTRIME DYSPLASIA	0.00806452	0.3020612885385351
MEIER-GORLIN SYNDROME 6; MGORS6	0.00806452	0.3020612885385351
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00806452	0.3020612885385351
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00806452	0.3020612885385351
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00806452	0.3020612885385351
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00806452	0.3020612885385351
BRITTLE CORNEA SYNDROME	0.00806452	0.3020612885385351
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00806452	0.3020612885385351
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00806452	0.3020612885385351
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00806452	0.3020612885385351
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00806452	0.3020612885385351
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.3020612885385351
ATYPICAL WERNER SYNDROME	0.00806452	0.3020612885385351
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00806452	0.3020612885385351
SMITH-MAGENIS SYNDROME	0.007825593	0.2931121387457828
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.007825593	0.2931121387457828
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.007660999999999999	0.2869472121705591
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.007660999999999999	0.2869472121705591
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.007660999999999999	0.2869472121705591
CARTILAGE-HAIR HYPOPLASIA	0.007660999999999999	0.2869472121705591
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.284205613405119
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.284205613405119
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.284205613405119
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.284205613405119
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.284205613405119
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.284205613405119
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.284205613405119
SARCOSINEMIA	0.007587804	0.284205613405119
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28405073457437563
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28405073457437563
ATYPICAL RETT SYNDROME	0.007576559	0.28378442538777693
RETT SYNDROME	0.007576559	0.28378442538777693
2Q31.1 MICRODELETION SYNDROME	0.007492273000000001	0.2806274442201738
11Q22.2Q22.3 MICRODELETION SYNDROME	0.007492273000000001	0.2806274442201738
TETRASOMY 5P	0.0074077330000000005	0.2774609493347934
MONOSOMY 22Q13.3	0.0074077330000000005	0.2774609493347934
MAN1B1-CDG	0.0074077330000000005	0.2774609493347934
PHELAN-MCDERMID SYNDROME	0.0074077330000000005	0.2774609493347934
SIMPSON-GOLABI-BEHMEL SYNDROME	0.0074077330000000005	0.2774609493347934
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0074077330000000005	0.2774609493347934
20Q11.2 MICRODUPLICATION SYNDROME	0.0074077330000000005	0.2774609493347934
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0074077330000000005	0.2774609493347934
1Q21.1 MICRODELETION SYNDROME	0.0074077330000000005	0.2774609493347934
ZTTK SYNDROME; ZTTKS	0.007361953000000001	0.2757462327999849
LARSEN-LIKE SYNDROME	0.007335394	0.27475145000295603
CRANIOFRONTONASAL SYNDROME; CFNS	0.007284174000000001	0.27283297510315496
FLOATING-HARBOR SYNDROME	0.007284174000000001	0.27283297510315496
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007201193	0.2697248734698009
GRACILE BONE DYSPLASIA; GCLEB	0.007201193	0.2697248734698009
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0071166530000000006	0.26655837858442055
BOHRING-OPITZ SYNDROME	0.0071166530000000006	0.26655837858442055
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0071166530000000006	0.26655837858442055
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0071166530000000006	0.26655837858442055
HEART AND BRAIN MALFORMATION SYNDROME	0.0071166530000000006	0.26655837858442055
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.0071166530000000006	0.26655837858442055
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.26377157093174775
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26377157093174775
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.26377157093174775
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.26377157093174775
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26377157093174775
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26377157093174775
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26377157093174775
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.26377157093174775
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26377157093174775
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26377157093174775
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26377157093174775
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26377157093174775
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26377157093174775
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26377157093174775
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26377157093174775
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26377157093174775
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26377157093174775
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26377157093174775
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26377157093174775
AMISH LETHAL MICROCEPHALY	0.00704225	0.26377157093174775
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26377157093174775
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26377157093174775
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.26377157093174775
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26377157093174775
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26377157093174775
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26377157093174775
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.007028633000000001	0.2632615382743759
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.007028633000000001	0.2632615382743759
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.007028633000000001	0.2632615382743759
RING CHROMOSOME 22 SYNDROME	0.007028633000000001	0.2632615382743759
CHARGE SYNDROME	0.006950854000000001	0.26034828057754594
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.0069467190000000005	0.2601934017468025
DUBOWITZ SYNDROME	0.0069467190000000005	0.2601934017468025
DUPLICATION/INVERSION 15Q11	0.0069467190000000005	0.2601934017468025
OCULODENTODIGITAL DYSPLASIA	0.0069467190000000005	0.2601934017468025
TRISOMY 12P	0.006866314	0.25718178569216554
LIG4 SYNDROME	0.006866314	0.25718178569216554
RENPENNING SYNDROME 1; RENS1	0.006862179	0.25702690686142216
WIEDEMANN-STEINER SYNDROME	0.006862179	0.25702690686142216
OHDO SYNDROME	0.006862179	0.25702690686142216
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0068621789999999995	0.2570269068614221
NEONATAL ADRENOLEUKODYSTROPHY	0.006816399000000001	0.2553121903266136
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00678984	0.25431740752958476
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00678984	0.25431740752958476
PMM2-CDG	0.006783333000000001	0.2540736840588116
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.006783333000000001	0.2540736840588116
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.006783333000000001	0.2540736840588116
19P13.13 MICRODELETION SYNDROME	0.006783333000000001	0.2540736840588116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006783333	0.25407368405881153
DISTAL MONOSOMY 1Q	0.006783333	0.25407368405881153
FRANK-TER HAAR SYNDROME	0.006738620000000001	0.25239893262978375
MATERNAL PHENYLKETONURIA	0.006732113	0.2521552091590104
SMITH-LEMLI-OPITZ SYNDROME	0.006732113	0.2521552091590104
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.006732113	0.2521552091590104
COFFIN-SIRIS SYNDROME 7; CSS7	0.006659773999999999	0.24944570982717304
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.006659773999999999	0.24944570982717304
20P13 MICRODELETION SYNDROME	0.006655639	0.24929083099642968
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.006575234	0.2462792149417927
STEEL SYNDROME; STLS	0.006575234	0.2462792149417927
SYNDROMIC DIARRHEA	0.006575234	0.2462792149417927
ZECHI-CEIDE SYNDROME	0.006575234	0.2462792149417927
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.006571099	0.2461243361110493
14Q12 MICRODELETION SYNDROME	0.006483079000000001	0.2428274958010046
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.006405300000000001	0.23991423810417473
JACOBSEN SYNDROME	0.006405300000000001	0.23991423810417473
URBAN-ROGERS-MEYER SYNDROME	0.006405300000000001	0.23991423810417473
CRANIOECTODERMAL DYSPLASIA	0.006405300000000001	0.23991423810417473
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.006405300000000001	0.23991423810417473
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.006405300000000001	0.23991423810417473
MOEBIUS SYNDROME	0.006405300000000001	0.23991423810417473
9P13 MICRODELETION SYNDROME	0.00632076	0.23674774321879427
CRANIOFACIAL DYSSYNOSTOSIS	0.00632076	0.23674774321879427
DUBOWITZ SYNDROME	0.00632076	0.23674774321879427
DE BARSY SYNDROME	0.0062419139999999994	0.23379452041618365
NOONAN SYNDROME 5; NS5	0.0062419139999999994	0.23379452041618365
FETAL TRIMETHADIONE SYNDROME	0.0062419139999999994	0.23379452041618365
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0062419139999999994	0.23379452041618365
JOUBERT SYNDROME 1	0.0062419139999999994	0.23379452041618365
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0062419139999999994	0.23379452041618365
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.006237779000000001	0.23363964158544026
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.006237779000000001	0.23363964158544026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.006237779000000001	0.23363964158544026
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.006237779000000001	0.23363964158544026
DISTAL MONOSOMY 9P	0.006190694	0.23187604551638258
MONOSOMY 18P	0.006190694	0.23187604551638258
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.006190694	0.23187604551638258
HALL-RIGGS SYNDROME	0.0061865589999999995	0.23172116668563916
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0061865589999999995	0.23172116668563916
OROFACIODIGITAL SYNDROME I; OFD1	0.0061865589999999995	0.23172116668563916
POTOCKI-SHAFFER SYNDROME	0.0061865589999999995	0.23172116668563916
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00611422	0.22901166735380182
ODONTOCHONDRODYSPLASIA; ODCD	0.00611422	0.22901166735380182
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00611422	0.22901166735380182
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00611422	0.22901166735380182
LARSEN SYNDROME	0.00611422	0.22901166735380182
KEIPERT SYNDROME; KPTS	0.00611422	0.22901166735380182
HYPERTELORISM, TEEBI TYPE; TBHS	0.00602968	0.22584517246842145
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00602968	0.22584517246842145
SHORT SYNDROME	0.00602968	0.22584517246842145
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00602968	0.22584517246842145
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00602968	0.22584517246842145
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00602968	0.22584517246842145
ZECHI-CEIDE SYNDROME	0.00602968	0.22584517246842145
TEEBI-SHALTOUT SYNDROME; TBSH	0.00602968	0.22584517246842145
AXENFELD-RIEGER SYNDROME	0.00602968	0.22584517246842145
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.005860953	0.21952540451803615
RUVALCABA SYNDROME	0.005860953	0.21952540451803615
2Q37 MICRODELETION SYNDROME	0.005860953	0.21952540451803615
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.005776413000000001	0.21635890963265578
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.005696359999999999	0.2133604779428124
NASODIGITOACOUSTIC SYNDROME	0.005696359999999999	0.2133604779428124
CEREBROOCULONASAL SYNDROME	0.005696359999999999	0.2133604779428124
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.005696359999999999	0.2133604779428124
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.005696359999999999	0.2133604779428124
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.005696359999999999	0.2133604779428124
CEREBROOCULONASAL SYNDROME	0.005696359999999999	0.2133604779428124
CRANIOECTODERMAL DYSPLASIA 1	0.00564514	0.21144200304301133
FRONTONASAL DYSPLASIA 1; FND1	0.00564514	0.21144200304301133
ACRODYSOSTOSIS	0.00564514	0.21144200304301133
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00564514	0.21144200304301133
GORLIN SYNDROME	0.00564514	0.21144200304301133
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00564514	0.21144200304301133
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.005443093	0.20387421510704673
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.005443093	0.20387421510704673
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.005443093	0.20387421510704673
48,XXXY SYNDROME	0.005443093	0.20387421510704673
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.005443093	0.20387421510704673
49,XXXXY SYNDROME	0.005443093	0.20387421510704673
19P13.12 MICRODELETION SYNDROME	0.005443093	0.20387421510704673
TETRASOMY 9P	0.005443093	0.20387421510704673
15Q11Q13 MICRODUPLICATION SYNDROME	0.0054430929999999995	0.2038742151070467
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.005397313000000001	0.2021594985722382
CANAVAN DISEASE	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.005397313000000001	0.2021594985722382
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005397313000000001	0.2021594985722382
KLEEFSTRA SYNDROME	0.005397313000000001	0.2021594985722382
AICARDI-GOUTIERES SYNDROME 7	0.005397313000000001	0.2021594985722382
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.005397313000000001	0.2021594985722382
OPTIC PATHWAY GLIOMA	0.005397313000000001	0.2021594985722382
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.005397313000000001	0.2021594985722382
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.005397313000000001	0.2021594985722382
CHÉDIAK-HIGASHI SYNDROME	0.005397313000000001	0.2021594985722382
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.005397313000000001	0.2021594985722382
MULTIPLE SULFATASE DEFICIENCY	0.005397313000000001	0.2021594985722382
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005397313000000001	0.2021594985722382
SCHINDLER DISEASE, TYPE I	0.005397313000000001	0.2021594985722382
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005397313000000001	0.2021594985722382
HSD10 DISEASE	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.005397313000000001	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.005397313000000001	0.2021594985722382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.005397313000000001	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.005397313000000001	0.2021594985722382
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.005397313000000001	0.2021594985722382
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.005397313000000001	0.2021594985722382
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005397313000000001	0.2021594985722382
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.005397313000000001	0.2021594985722382
NIEMANN-PICK DISEASE TYPE C	0.005397313000000001	0.2021594985722382
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005397313000000001	0.2021594985722382
TAY-SACHS DISEASE	0.005397313000000001	0.2021594985722382
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.005397313000000001	0.2021594985722382
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.005397313000000001	0.2021594985722382
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.005397313000000001	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.005397313000000001	0.2021594985722382
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.005397313000000001	0.2021594985722382
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005397313000000001	0.2021594985722382
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.005397313000000001	0.2021594985722382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.005397313000000001	0.2021594985722382
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.005397313000000001	0.2021594985722382
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.005397313000000001	0.2021594985722382
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005397313000000001	0.2021594985722382
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005397313000000001	0.2021594985722382
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.005397313000000001	0.2021594985722382
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.005397313000000001	0.2021594985722382
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005397313000000001	0.2021594985722382
%300712 CRANIOFACIOSKELETAL SYNDROME	0.005319534000000001	0.19924624087540832
TEMTAMY SYNDROME	0.005319534000000001	0.19924624087540832
TRISOMY 9P	0.005319534000000001	0.19924624087540832
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.005319534000000001	0.19924624087540832
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.005319534	0.19924624087540826
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.005319534	0.19924624087540826
TRISOMY 8P	0.005315399	0.19909136204466488
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.005315399	0.19909136204466488
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.005315399	0.19909136204466488
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.005234994000000001	0.19607974599002792
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.005230859000000001	0.19592486715928453
FRYNS SYNDROME	0.005230859000000001	0.19592486715928453
HENNEKAM-BEEMER SYNDROME	0.005230859000000001	0.19592486715928453
INTELLECTUAL DISABILITY, WOLFF TYPE	0.005230859000000001	0.19592486715928453
15Q OVERGROWTH SYNDROME	0.005230859000000001	0.19592486715928453
PETTIGREW SYNDROME	0.005152013	0.1929716443566739
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.005152013	0.1929716443566739
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.005152013	0.1929716443566739
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.005152013	0.1929716443566739
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.005152013	0.1929716443566739
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.005152013	0.1929716443566739
WEBB-DATTANI SYNDROME; WEDAS	0.005152013	0.1929716443566739
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.005152013	0.1929716443566739
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.005152013	0.1929716443566739
DESANTO-SHINAWI SYNDROME	0.005152013	0.1929716443566739
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.005152013	0.1929716443566739
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.005152013	0.1929716443566739
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.005152013	0.1929716443566739
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005152013	0.1929716443566739
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.005152013	0.1929716443566739
FUCOSIDOSIS	0.005152013	0.1929716443566739
SOTOS SYNDROME	0.005152013	0.1929716443566739
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.005152013	0.1929716443566739
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0051520129999999996	0.19297164435667385
SMITH-MAGENIS SYNDROME; SMS	0.005100792999999999	0.19105316945687278
DISTAL MONOSOMY 6P	0.004901674	0.18359505146441887
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.004901674	0.18359505146441887
6Q16 MICRODELETION SYNDROME	0.004901674	0.18359505146441887
14Q22Q23 MICRODELETION SYNDROME	0.004901674	0.18359505146441887
17Q21.31 MICRODUPLICATION SYNDROME	0.004901674	0.18359505146441887
DISTAL MONOSOMY 3P	0.004897539	0.18344017263367546
RENPENNING SYNDROME	0.004897539	0.18344017263367546
C SYNDROME	0.004897539	0.18344017263367546
MILLER-DIEKER SYNDROME	0.004897539	0.18344017263367546
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.004897539	0.18344017263367546
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.004855894	0.18188033492961034
HYPERMANGANESEMIA WITH DYSTONIA 2	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.004855894	0.18188033492961034
AICARDI-GOUTIERES SYNDROME 6	0.004855894	0.18188033492961034
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.004855894	0.18188033492961034
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.004855894	0.18188033492961034
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.004855894	0.18188033492961034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004855894	0.18188033492961034
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.004855894	0.18188033492961034
CHILDHOOD DISINTEGRATIVE DISORDER	0.004851759000000001	0.18172545609886695
MENKES DISEASE	0.004851759000000001	0.18172545609886695
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.004851759000000001	0.18172545609886695
ALEXANDER DISEASE	0.004851759000000001	0.18172545609886695
CADASIL	0.004851759000000001	0.18172545609886695
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004851759000000001	0.18172545609886695
FLYNN-AIRD SYNDROME	0.004851759000000001	0.18172545609886695
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.004851759000000001	0.18172545609886695
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.004851759000000001	0.18172545609886695
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.004851759000000001	0.18172545609886695
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.004851759000000001	0.18172545609886695
NORRIE DISEASE	0.004851759000000001	0.18172545609886695
SNEDDON SYNDROME	0.004851759000000001	0.18172545609886695
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.004851759000000001	0.18172545609886695
NASU-HAKOLA DISEASE	0.004851759000000001	0.18172545609886695
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.004851759000000001	0.18172545609886695
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.004851759000000001	0.18172545609886695
LYNCH SYNDROME	0.004851759000000001	0.18172545609886695
CHOREOACANTHOCYTOSIS	0.004851759000000001	0.18172545609886695
NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.18172545609886695
DILATED CARDIOMYOPATHY WITH ATAXIA	0.004851759000000001	0.18172545609886695
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.004851759000000001	0.18172545609886695
BEHÇET DISEASE	0.004851759000000001	0.18172545609886695
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004851759000000001	0.18172545609886695
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004851759000000001	0.18172545609886695
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004851759000000001	0.18172545609886695
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.18172545609886695
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.004851759000000001	0.18172545609886695
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004851759000000001	0.18172545609886695
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.004851759000000001	0.18172545609886695
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004851759000000001	0.18172545609886695
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.004851759000000001	0.18172545609886695
METACHROMATIC LEUKODYSTROPHY	0.004851759000000001	0.18172545609886695
ETHYLMALONIC ENCEPHALOPATHY	0.004851759000000001	0.18172545609886695
ADIPOSIS DOLOROSA	0.004851759000000001	0.18172545609886695
TRIPLE A SYNDROME	0.004851759000000001	0.18172545609886695
RETT SYNDROME, CONGENITAL VARIANT	0.004851759000000001	0.18172545609886695
FAMILIAL COLORECTAL CANCER TYPE X	0.004851759000000001	0.18172545609886695
ASPARTYLGLUCOSAMINURIA; AGU	0.004851759000000001	0.18172545609886695
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004851759000000001	0.18172545609886695
KRABBE DISEASE	0.004851759000000001	0.18172545609886695
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.004851759000000001	0.18172545609886695
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.004851759000000001	0.18172545609886695
ALEXANDER DISEASE	0.004851759000000001	0.18172545609886695
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.004851759000000001	0.18172545609886695
COG8-CDG	0.004851759000000001	0.18172545609886695
GM2 GANGLIOSIDOSIS, AB VARIANT	0.004851759000000001	0.18172545609886695
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.004851759000000001	0.18172545609886695
WOLFRAM SYNDROME	0.004851759000000001	0.18172545609886695
INFANTILE NEUROAXONAL DYSTROPHY	0.004851759000000001	0.18172545609886695
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.004851759000000001	0.18172545609886695
RETT SYNDROME; RTT	0.004851759000000001	0.18172545609886695
CEREBROTENDINOUS XANTHOMATOSIS	0.004851759000000001	0.18172545609886695
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.004851759000000001	0.18172545609886695
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.004851759000000001	0.18172545609886695
XERODERMA PIGMENTOSUM	0.004851759000000001	0.18172545609886695
WHIPPLE DISEASE	0.004851759000000001	0.18172545609886695
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.004851759000000001	0.18172545609886695
FABRY DISEASE	0.004851759000000001	0.18172545609886695
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.004773980000000001	0.17881219840203705
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.004773980000000001	0.17881219840203705
WEYERS ACROFACIAL DYSOSTOSIS	0.004773980000000001	0.17881219840203705
PROXIMAL SYMPHALANGISM	0.004773980000000001	0.17881219840203705
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.004773980000000001	0.17881219840203705
BANKI SYNDROME	0.004773980000000001	0.17881219840203705
ROIFMAN SYNDROME	0.004773980000000001	0.17881219840203705
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.004773980000000001	0.17881219840203705
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.004773980000000001	0.17881219840203705
NOONAN SYNDROME	0.004773980000000001	0.17881219840203705
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.004773980000000001	0.17881219840203705
PERIPHERAL DYSOSTOSIS	0.004773980000000001	0.17881219840203705
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.004773980000000001	0.17881219840203705
FEINGOLD SYNDROME	0.004773980000000001	0.17881219840203705
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.004773980000000001	0.17881219840203705
CLEIDOCRANIAL DYSPLASIA	0.004773980000000001	0.17881219840203705
HAND-FOOT-GENITAL SYNDROME; HFG	0.004773980000000001	0.17881219840203705
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.004773980000000001	0.17881219840203705
MESOMELIA-SYNOSTOSES SYNDROME	0.004773980000000001	0.17881219840203705
TETRALOGY OF FALLOT	0.004773980000000001	0.17881219840203705
HOLOPROSENCEPHALY	0.0047674729999999995	0.17856847493126377
OROFACIODIGITAL SYNDROME TYPE 6	0.0047674729999999995	0.17856847493126377
DISTAL MONOSOMY 10P	0.0046894400000000004	0.17564570351665665
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.0046894400000000004	0.17564570351665665
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0046894400000000004	0.17564570351665665
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0046894400000000004	0.17564570351665665
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0046894400000000004	0.17564570351665665
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.0046894400000000004	0.17564570351665665
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0046894400000000004	0.17564570351665665
FRONTONASAL DYSPLASIA	0.0046894400000000004	0.17564570351665665
RING CHROMOSOME 1 SYNDROME	0.0046894400000000004	0.17564570351665665
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0046894400000000004	0.17564570351665665
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.004682933	0.17540198004588342
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004682933	0.17540198004588342
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004682933	0.17540198004588342
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.004682933	0.17540198004588342
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004682933	0.17540198004588342
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004682933	0.17540198004588342
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004682933	0.17540198004588342
KOOLEN-DE VRIES SYNDROME	0.004682933	0.17540198004588342
CHROMOSOME 10Q26 DELETION SYNDROME	0.004682933	0.17540198004588342
C SYNDROME	0.004682933	0.17540198004588342
8P23.1 MICRODELETION SYNDROME	0.004682933	0.17540198004588342
22Q11.2 DELETION SYNDROME	0.004682933	0.17540198004588342
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004682933	0.17540198004588342
COFFIN-SIRIS SYNDROME	0.004682933	0.17540198004588342
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004682933	0.17540198004588342
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004682933	0.17540198004588342
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004682933	0.17540198004588342
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.004682933	0.17540198004588342
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.004682933	0.17540198004588342
20P12.3 MICRODELETION SYNDROME	0.004682933	0.17540198004588342
OCULOECTODERMAL SYNDROME; OES	0.004682933	0.17540198004588342
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004682933	0.17540198004588342
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.004610594	0.17269248071404603
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004610594	0.17269248071404603
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.004610594	0.17269248071404603
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.004610594	0.17269248071404603
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.004610594	0.17269248071404603
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.004610594	0.17269248071404603
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.004610594	0.17269248071404603
SAUL-WILSON SYNDROME; SWILS	0.004610594	0.17269248071404603
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004610594	0.17269248071404603
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.004610594	0.17269248071404603
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.004610594	0.17269248071404603
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.004610594	0.17269248071404603
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.004610594	0.17269248071404603
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.004610594	0.17269248071404603
MENTAL RETARDATION, X-LINKED 99	0.004610594	0.17269248071404603
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.004610594	0.17269248071404603
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.004610594	0.17269248071404603
ATKIN-FLAITZ SYNDROME	0.004606459	0.17253760188330264
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.004606459	0.17253760188330264
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.004606459	0.17253760188330264
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.004606459	0.17253760188330264
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.004606459	0.17253760188330264
AICA-RIBOSIDURIA	0.004606459	0.17253760188330264
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004606459	0.17253760188330264
NOONAN SYNDROME 7; NS7	0.004606459	0.17253760188330264
CLARK-BARAITSER SYNDROME	0.004606459	0.17253760188330264
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.004606459	0.17253760188330264
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.004606459	0.17253760188330264
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004559374	0.17077400581424496
TRISOMY 8Q	0.004559374	0.17077400581424496
ELSAHY-WATERS SYNDROME; ESWS	0.004559374	0.17077400581424496
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.004559374	0.17077400581424496
3C SYNDROME	0.004559374	0.17077400581424496
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.004555239	0.17061912698350157
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555239	0.17061912698350157
AYME-GRIPP SYNDROME; AYGRP	0.004555239	0.17061912698350157
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00435612	0.1631610089910476
KEIPERT SYNDROME	0.00435612	0.1631610089910476
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00435612	0.1631610089910476
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00435612	0.1631610089910476
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00435612	0.1631610089910476
FRAXE INTELLECTUAL DISABILITY	0.00435612	0.1631610089910476
WHITE FORELOCK WITH MALFORMATIONS	0.00435612	0.1631610089910476
WILLIAMS-BEUREN SYNDROME; WBS	0.00435612	0.1631610089910476
MONOSOMY 22	0.00435612	0.1631610089910476
PENOSCROTAL TRANSPOSITION	0.00435612	0.1631610089910476
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00435612	0.1631610089910476
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00431034	0.1614462924562391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.1614462924562391
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00431034	0.1614462924562391
NEUROFERRITINOPATHY	0.00431034	0.1614462924562391
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.1614462924562391
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.1614462924562391
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00431034	0.1614462924562391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.1614462924562391
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00431034	0.1614462924562391
DYSOSTEOSCLEROSIS	0.00431034	0.1614462924562391
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.1614462924562391
TRISOMY 5P	0.00431034	0.1614462924562391
HUNTINGTON DISEASE	0.00431034	0.1614462924562391
REFSUM DISEASE	0.00431034	0.1614462924562391
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.1614462924562391
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.1614462924562391
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.1614462924562391
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.1614462924562391
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.1614462924562391
ATAXIA WITH VITAMIN E DEFICIENCY	0.00431034	0.1614462924562391
PANDAS	0.00431034	0.1614462924562391
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.1614462924562391
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004226054	0.15828931128863594
PHENOBARBITAL EMBRYOPATHY	0.004226054	0.15828931128863594
OROFACIODIGITAL SYNDROME VI	0.004226054	0.15828931128863594
PSEUDOAMINOPTERIN SYNDROME	0.004226054	0.15828931128863594
BARATELA-SCOTT SYNDROME	0.004226054	0.15828931128863594
CODAS SYNDROME	0.004226054	0.15828931128863594
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004226054	0.15828931128863594
WOLCOTT-RALLISON SYNDROME	0.004221918999999999	0.15813443245789252
COFFIN-LOWRY SYNDROME	0.004221918999999999	0.15813443245789252
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.004221918999999999	0.15813443245789252
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004221918999999999	0.15813443245789252
FOUNTAIN SYNDROME	0.004221918999999999	0.15813443245789252
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.004221918999999999	0.15813443245789252
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004141514	0.15512281640325556
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.004141514	0.15512281640325556
JOUBERT SYNDROME 10	0.004141514	0.15512281640325556
8Q12 MICRODUPLICATION SYNDROME	0.004141514	0.15512281640325556
CHROMOSOME 16Q22 DELETION SYNDROME	0.004141514	0.15512281640325556
CHROMOSOME 9P DELETION SYNDROME	0.004141514	0.15512281640325556
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.004141514	0.15512281640325556
COHEN-GIBSON SYNDROME; COGIS	0.004141514	0.15512281640325556
NOONAN SYNDROME 6; NS6	0.004141514	0.15512281640325556
LAMB-SHAFFER SYNDROME	0.004141514	0.15512281640325556
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004141514	0.15512281640325556
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.004141514	0.15512281640325556
CEREBROFACIOARTICULAR SYNDROME	0.004141514	0.15512281640325556
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.004141514	0.15512281640325556
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.004137379	0.15496793757251215
MOWAT-WILSON SYNDROME	0.004137379	0.15496793757251215
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.004137379	0.15496793757251215
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.004137379	0.15496793757251215
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.004137379	0.15496793757251215
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.004137379	0.15496793757251215
HENNEKAM SYNDROME	0.004137379	0.15496793757251215
LATHOSTEROLOSIS	0.004137379	0.15496793757251215
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00406504	0.15225843824067478
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00406504	0.15225843824067478
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00406504	0.15225843824067478
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00406504	0.15225843824067478
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00406504	0.15225843824067478
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00406504	0.15225843824067478
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00406504	0.15225843824067478
TRICHOHEPATOENTERIC SYNDROME 1	0.00406504	0.15225843824067478
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00406504	0.15225843824067478
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00406504	0.15225843824067478
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00406504	0.15225843824067478
TRICHOHEPATOENTERIC SYNDROME 2	0.00406504	0.15225843824067478
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00406504	0.15225843824067478
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00406504	0.15225843824067478
FG SYNDROME 2; FGS2	0.00406504	0.15225843824067478
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00406504	0.15225843824067478
TETRASOMY 12P	0.00406504	0.15225843824067478
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00406504	0.15225843824067478
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00406504	0.15225843824067478
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00406504	0.15225843824067478
MARSHALL-SMITH SYNDROME	0.00406504	0.15225843824067478
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00406504	0.15225843824067478
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00406504	0.15225843824067478
OSTEOGENESIS IMPERFECTA, TYPE X	0.00406504	0.15225843824067478
268650 RUDIGER SYNDROME	0.00406504	0.15225843824067478
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00406504	0.15225843824067478
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00406504	0.15225843824067478
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.00406504	0.15225843824067478
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00406504	0.15225843824067478
MENTAL RETARDATION, X-LINKED 19	0.00406504	0.15225843824067478
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00406504	0.15225843824067478
MARSHALL-SMITH SYNDROME; MRSHSS	0.00406504	0.15225843824067478
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00406504	0.15225843824067478
MENTAL RETARDATION, X-LINKED 93	0.00406504	0.15225843824067478
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00406504	0.15225843824067478
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.15033996334087368
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.15033996334087368
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.15033996334087368
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0040138199999999995	0.15033996334087368
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.0040138199999999995	0.15033996334087368
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0040138199999999995	0.15033996334087368
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.15033996334087368
BASAL CELL NEVUS SYNDROME	0.0040138199999999995	0.15033996334087368
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.15033996334087368
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0040138199999999995	0.15033996334087368
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0040138199999999995	0.15033996334087368
GENITOPALATOCARDIAC SYNDROME	0.0040138199999999995	0.15033996334087368
608028 THAI SYMPHALANGISM SYNDROME	0.0040138199999999995	0.15033996334087368
CHARLIE M SYNDROME	0.0040138199999999995	0.15033996334087368
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0040138199999999995	0.15033996334087368
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.15033996334087368
ROBERTS SYNDROME; RBS	0.0040138199999999995	0.15033996334087368
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0040138199999999995	0.15033996334087368
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0040138199999999995	0.15033996334087368
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.15033996334087368
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0040138199999999995	0.15033996334087368
ACROOSTEOLYSIS DOMINANT TYPE	0.0040138199999999995	0.15033996334087368
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.0040138199999999995	0.15033996334087368
MULTIPLE METAPHYSEAL DYSPLASIA	0.0040138199999999995	0.15033996334087368
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0040138199999999995	0.15033996334087368
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.15033996334087368
RECOMBINANT 8 SYNDROME	0.0038117730000000005	0.1427721754049091
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0038117730000000005	0.1427721754049091
CATEL-MANZKE SYNDROME; CATMANS	0.0038117730000000005	0.1427721754049091
RECOMBINANT CHROMOSOME 8 SYNDROME	0.0038117730000000005	0.1427721754049091
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0038117730000000005	0.1427721754049091
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0038117730000000005	0.1427721754049091
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.0038117730000000005	0.1427721754049091
CHROMOSOME 16P13.3 DELETION SYNDROME	0.0038117730000000005	0.1427721754049091
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0038117730000000005	0.1427721754049091
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0038117730000000005	0.1427721754049091
COHEN SYNDROME	0.0038117730000000005	0.1427721754049091
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0038117730000000005	0.1427721754049091
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0038117730000000005	0.1427721754049091
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.003811773	0.14277217540490908
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.003811773	0.14277217540490908
DPAGT1-CDG	0.003811773	0.14277217540490908
ACROCEPHALOPOLYDACTYLY	0.0036804999999999997	0.13785526881526466
CAREY-FINEMAN-ZITER SYNDROME	0.0036804999999999997	0.13785526881526466
MOEBIUS SYNDROME; MBS	0.0036804999999999997	0.13785526881526466
OROFACIODIGITAL SYNDROME IV; OFD4	0.0036804999999999997	0.13785526881526466
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0036804999999999997	0.13785526881526466
FRONTORHINY	0.0036804999999999997	0.13785526881526466
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0036804999999999997	0.13785526881526466
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0036804999999999997	0.13785526881526466
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0036804999999999997	0.13785526881526466
16P12.1P12.3 TRIPLICATION SYNDROME	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0036804999999999997	0.13785526881526466
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0036804999999999997	0.13785526881526466
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0036804999999999997	0.13785526881526466
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.0036804999999999997	0.13785526881526466
LAURENCE-MOON SYNDROME	0.0036804999999999997	0.13785526881526466
SILLENCE SYNDROME	0.0036804999999999997	0.13785526881526466
ABRUZZO-ERICKSON SYNDROME	0.0036804999999999997	0.13785526881526466
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0036804999999999997	0.13785526881526466
DISTAL TRISOMY 5Q	0.0036804999999999997	0.13785526881526466
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0036804999999999997	0.13785526881526466
RING CHROMOSOME 13 SYNDROME	0.00359596	0.1346887739298843
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00359596	0.1346887739298843
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00359596	0.1346887739298843
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00359596	0.1346887739298843
CRI-DU-CHAT SYNDROME	0.00359596	0.1346887739298843
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00359596	0.1346887739298843
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00359596	0.1346887739298843
MONOSOMY 5P	0.00359596	0.1346887739298843
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00359596	0.1346887739298843
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00359596	0.1346887739298843
SCARF SYNDROME	0.00359596	0.1346887739298843
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00359596	0.1346887739298843
SHPRINTZEN OMPHALOCELE SYNDROME	0.00359596	0.1346887739298843
RING CHROMOSOME 6 SYNDROME	0.00359596	0.1346887739298843
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00359596	0.1346887739298843
FEINGOLD SYNDROME 1; FGLDS1	0.00359596	0.1346887739298843
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00359596	0.1346887739298843
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00359596	0.1346887739298843
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00359596	0.1346887739298843
3Q13 MICRODELETION SYNDROME	0.00359596	0.1346887739298843
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00359596	0.1346887739298843
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00359596	0.1346887739298843
600736 VELOFACIOSKELETAL SYNDROME	0.00359596	0.1346887739298843
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00359596	0.1346887739298843
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00359596	0.1346887739298843
JOUBERT SYNDROME 3; JBTS3	0.00359596	0.1346887739298843
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00359596	0.1346887739298843
OMODYSPLASIA 1; OMOD1	0.00359596	0.1346887739298843
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00359596	0.1346887739298843
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.0032703540000000005	0.12249301176228125
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032703540000000005	0.12249301176228125
12Q14 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228125
17P13.3 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.12249301176228125
CHAR SYNDROME	0.0032703540000000005	0.12249301176228125
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0032703540000000005	0.12249301176228125
2Q32Q33 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228125
EAR-PATELLA-SHORT STATURE SYNDROME	0.0032703540000000005	0.12249301176228125
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0032703540000000005	0.12249301176228125
SILVER-RUSSELL SYNDROME; SRS	0.0032703540000000005	0.12249301176228125
CHAR SYNDROME	0.0032703540000000005	0.12249301176228125
DISTAL TRISOMY 18Q	0.0032703540000000005	0.12249301176228125
3Q29 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228125
OCULOFACIOCARDIODENTAL SYNDROME	0.0032703540000000005	0.12249301176228125
POPOV-CHANG SYNDROME; POPCHAS	0.0032703540000000005	0.12249301176228125
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0032703540000000005	0.12249301176228125
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.0032662190000000003	0.12233813293153785
BOWEN-CONRADI SYNDROME	0.0032662190000000003	0.12233813293153785
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0032662190000000003	0.12233813293153785
SECKEL SYNDROME 1; SCKL1	0.0032662190000000003	0.12233813293153785
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0032662190000000003	0.12233813293153785
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0032662190000000003	0.12233813293153785
MICROPHTHALMIA, LENZ TYPE	0.0032662190000000003	0.12233813293153785
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.0032662190000000003	0.12233813293153785
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.0032662190000000003	0.12233813293153785
WARBURG MICRO SYNDROME 3; WARBM3	0.0032662190000000003	0.12233813293153785
PROTEUS SYNDROME	0.0032662190000000003	0.12233813293153785
BRANCHIOOCULOFACIAL SYNDROME	0.0032662190000000003	0.12233813293153785
CORNELIA DE LANGE SYNDROME 1	0.0032662190000000003	0.12233813293153785
COWDEN SYNDROME	0.0031361529999999996	0.11746643522912613
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0031361529999999996	0.11746643522912613
SCHAAF-YANG SYNDROME; SHFYNG	0.0031361529999999996	0.11746643522912613
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.0031361529999999996	0.11746643522912613
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0031361529999999996	0.11746643522912613
TEMTAMY SYNDROME; TEMTYS	0.0031361529999999996	0.11746643522912613
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0031361529999999996	0.11746643522912613
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0031361529999999996	0.11746643522912613
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.0031361529999999996	0.11746643522912613
MYHRE SYNDROME	0.0031361529999999996	0.11746643522912613
COFFIN-SIRIS SYNDROME 2; CSS2	0.0031361529999999996	0.11746643522912613
ADAMS-OLIVER SYNDROME 1; AOS1	0.0031361529999999996	0.11746643522912613
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.003051613	0.11429994034374577
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.003051613	0.11429994034374577
MENTAL RETARDATION, X-LINKED 104; MRX104	0.003051613	0.11429994034374577
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.003051613	0.11429994034374577
3Q29 MICRODUPLICATION SYNDROME	0.003051613	0.11429994034374577
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003051613	0.11429994034374577
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003051613	0.11429994034374577
BOHRING-OPITZ SYNDROME	0.003051613	0.11429994034374577
MICRO SYNDROME	0.003051613	0.11429994034374577
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.003051613	0.11429994034374577
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.003051613	0.11429994034374577
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.003051613	0.11429994034374577
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.003051613	0.11429994034374577
MOSAIC TRISOMY 14	0.003051613	0.11429994034374577
CHROMOSOME 1P35 DELETION SYNDROME	0.003051613	0.11429994034374577
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.003051613	0.11429994034374577
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.003051613	0.11429994034374577
TARP SYNDROME	0.003051613	0.11429994034374577
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.003051613	0.11429994034374577
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.003051613	0.11429994034374577
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.003051613	0.11429994034374577
KABUKI SYNDROME 1	0.003051613	0.11429994034374577
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.003051613	0.11429994034374577
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.003051613	0.11429994034374577
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.003051613	0.11429994034374577
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.003051613	0.11429994034374577
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.003051613	0.11429994034374577
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027248000000000003	0.10205896928890999
WT LIMB-BLOOD SYNDROME	0.0027248000000000003	0.10205896928890999
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0027248000000000003	0.10205896928890999
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0027248000000000003	0.10205896928890999
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.0027248000000000003	0.10205896928890999
GORDON SYNDROME	0.0027248000000000003	0.10205896928890999
TALONAVICULAR COALITION	0.0027248000000000003	0.10205896928890999
FIBROCHONDROGENESIS 1; FBCG1	0.0027248000000000003	0.10205896928890999
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0027248000000000003	0.10205896928890999
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0027248000000000003	0.10205896928890999
MEIER-GORLIN SYNDROME 1; MGORS1	0.0027248000000000003	0.10205896928890999
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0027248000000000003	0.10205896928890999
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0027248000000000003	0.10205896928890999
JOHANSON-BLIZZARD SYNDROME; JBS	0.0027248000000000003	0.10205896928890999
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0027248000000000003	0.10205896928890999
3MC SYNDROME 1	0.0027248000000000003	0.10205896928890999
MICROCEPHALY-CARDIOMYOPATHY	0.0027248000000000003	0.10205896928890999
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0027248000000000003	0.10205896928890999
MASA SYNDROME	0.0027248000000000003	0.10205896928890999
DENTAL ANKYLOSIS	0.0027248000000000003	0.10205896928890999
HAND-FOOT-GENITAL SYNDROME	0.0027248000000000003	0.10205896928890999
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0027248000000000003	0.10205896928890999
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0027248000000000003	0.10205896928890999
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0027248000000000003	0.10205896928890999
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.0027248000000000003	0.10205896928890999
19Q13.11 MICRODELETION SYNDROME	0.0027248000000000003	0.10205896928890999
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0027248000000000003	0.10205896928890999
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.0027248000000000003	0.10205896928890999
HALLUX VARUS-PREAXIAL POLYSYNDACTYLY SYNDROME	0.0027248000000000003	0.10205896928890999
BRACHYDACTYLY TYPE C	0.0027248000000000003	0.10205896928890999
BRACHYDACTYLY TYPE A1	0.0027248000000000003	0.10205896928890999
BRACHYDACTYLY TYPE A2	0.0027248000000000003	0.10205896928890999
BRACHYDACTYLY TYPE A7	0.0027248000000000003	0.10205896928890999
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0027248000000000003	0.10205896928890999
HALLERMANN-STREIFF SYNDROME	0.0027248000000000003	0.10205896928890999
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0027248000000000003	0.10205896928890999
BLOOM SYNDROME	0.0027248000000000003	0.10205896928890999
BOWEN-CONRADI SYNDROME	0.0027248000000000003	0.10205896928890999
TETRALOGY OF FALLOT	0.0027248000000000003	0.10205896928890999
ANONYCHIA-MICROCEPHALY SYNDROME	0.0027248000000000003	0.10205896928890999
SYNDACTYLY TYPE 5	0.0027248000000000003	0.10205896928890999
SYNDACTYLY TYPE 2	0.0027248000000000003	0.10205896928890999
MOSAIC TRISOMY 8	0.0027248000000000003	0.10205896928890999
NAIL-PATELLA SYNDROME	0.0027248000000000003	0.10205896928890999
CEREBROCOSTOMANDIBULAR SYNDROME	0.0027248000000000003	0.10205896928890999
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.0027248000000000003	0.10205896928890999
HUNTER-MACDONALD SYNDROME	0.0027248000000000003	0.10205896928890999
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928890999
TOWNES-BROCKS SYNDROME	0.0027248000000000003	0.10205896928890999
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0027248000000000003	0.10205896928890999
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928890999
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0027248000000000003	0.10205896928890999
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0027248000000000003	0.10205896928890999
SECKEL SYNDROME 5; SCKL5	0.0027248000000000003	0.10205896928890999
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0027248000000000003	0.10205896928890999
BRACHYDACTYLY, TYPE A3	0.0027248000000000003	0.10205896928890999
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.0027248000000000003	0.10205896928890999
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.0027248000000000003	0.10205896928890999
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0027248000000000003	0.10205896928890999
OSLAM SYNDROME	0.0027248000000000003	0.10205896928890999
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.0027248000000000003	0.10205896928890999
ALAGILLE SYNDROME	0.0027248000000000003	0.10205896928890999
PELVIS-SHOULDER DYSPLASIA	0.0027248000000000003	0.10205896928890999
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928890999
DESBUQUOIS SYNDROME	0.0027248000000000003	0.10205896928890999
MOLAR I REINCLUSION	0.0027248000000000003	0.10205896928890999
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.10205896928890999
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.0027248000000000003	0.10205896928890999
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0027248000000000003	0.10205896928890999
BRACHYDACTYLY, TYPE A2; BDA2	0.0027248000000000003	0.10205896928890999
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0027248000000000003	0.10205896928890999
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0027248000000000003	0.10205896928890999
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.0027248000000000003	0.10205896928890999
LIMB-MAMMARY SYNDROME	0.0027248000000000003	0.10205896928890999
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.0027248000000000003	0.10205896928890999
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.0027248000000000003	0.10205896928890999
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0027248000000000003	0.10205896928890999
SYNPOLYDACTYLY 1	0.0027248000000000003	0.10205896928890999
ERMINE PHENOTYPE	0.0027248000000000003	0.10205896928890999
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.10205896928890999
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0027248000000000003	0.10205896928890999
SECKEL SYNDROME 2; SCKL2	0.0027248000000000003	0.10205896928890999
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.0027248000000000003	0.10205896928890999
3M SYNDROME	0.0027248000000000003	0.10205896928890999
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0027248000000000003	0.10205896928890999
METATROPIC DYSPLASIA	0.0027248000000000003	0.10205896928890999
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0027248000000000003	0.10205896928890999
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027248000000000003	0.10205896928890999
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.0027248000000000003	0.10205896928890999
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928890999
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0027248000000000003	0.10205896928890999
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.0027248000000000003	0.10205896928890999
CATEL-MANZKE SYNDROME	0.0027248000000000003	0.10205896928890999
FETAL MINOXIDIL SYNDROME	0.0027248000000000003	0.10205896928890999
BRACHYDACTYLY, TYPE A1, D	0.0027248000000000003	0.10205896928890999
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0027248000000000003	0.10205896928890999
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.0027248000000000003	0.10205896928890999
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.0027248000000000003	0.10205896928890999
FLOATING-HARBOR SYNDROME	0.0027248000000000003	0.10205896928890999
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002718293	0.10181524581813675
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.002718293	0.10181524581813675
MONOSOMY 18Q	0.002718293	0.10181524581813675
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002718293	0.10181524581813675
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002718293	0.10181524581813675
MENTAL RETARDATION, X-LINKED 91; MRX91	0.002718293	0.10181524581813675
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813675
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.10181524581813675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.002718293	0.10181524581813675
WEAVER SYNDROME	0.002718293	0.10181524581813675
LATHOSTEROLOSIS	0.002718293	0.10181524581813675
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002718293	0.10181524581813675
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002718293	0.10181524581813675
MONOSOMY 9P	0.002718293	0.10181524581813675
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002718293	0.10181524581813675
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.10181524581813675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002718293	0.10181524581813675
XQ25 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813675
POTOCKI-SHAFFER SYNDROME	0.002718293	0.10181524581813675
CK SYNDROME	0.002718293	0.10181524581813675
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002718293	0.10181524581813675
MONOSOMY 9Q22.3	0.002718293	0.10181524581813675
8P11.2 DELETION SYNDROME	0.002718293	0.10181524581813675
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.002718293	0.10181524581813675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002718293	0.10181524581813675
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.10181524581813675
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002718293	0.10181524581813675
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.002718293	0.10181524581813675
DISTAL TRISOMY 17Q	0.002718293	0.10181524581813675
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002718293	0.10181524581813675
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.002718293	0.10181524581813675
XQ25 DUPLICATION SYNDROME	0.002718293	0.10181524581813675
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.002718293	0.10181524581813675
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002718293	0.10181524581813675
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002718293	0.10181524581813675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002718293	0.10181524581813675
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002718293	0.10181524581813675
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.002718293	0.10181524581813675
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.002718293	0.10181524581813675
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.002718293	0.10181524581813675
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002718293	0.10181524581813675
PEHO SYNDROME; PEHO	0.002718293	0.10181524581813675
22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813675
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.09718727158649827
BARDET-BIEDL SYNDROME 1; BBS1	0.0025947339999999996	0.09718727158649827
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0025947339999999996	0.09718727158649827
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0025947339999999996	0.09718727158649827
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.09718727158649827
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.09718727158649827
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.09718727158649827
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.09718727158649827
GENITOPATELLAR SYNDROME; GTPTS	0.0025947339999999996	0.09718727158649827
20Q11.2 MICRODELETION SYNDROME	0.0025947339999999996	0.09718727158649827
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0025947339999999996	0.09718727158649827
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0025947339999999996	0.09718727158649827
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.09718727158649827
AL-RAQAD SYNDROME; ARS	0.0025947339999999996	0.09718727158649827
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.09718727158649827
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.09718727158649827
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0025947339999999996	0.09718727158649827
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.09718727158649827
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.09718727158649827
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.002590599	0.09703239275575488
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.002590599	0.09703239275575488
PGM3-CDG	0.002590599	0.09703239275575488
CONO-SPONDYLAR DYSPLASIA	0.002590599	0.09703239275575488
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.002590599	0.09703239275575488
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.09703239275575488
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.09703239275575488
KLEEFSTRA SYNDROME	0.002590599	0.09703239275575488
21Q22.11Q22.12 MICRODELETION SYNDROME	0.002590599	0.09703239275575488
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.002590599	0.09703239275575488
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.09703239275575488
CRANIOSYNOSTOSIS 2	0.002590599	0.09703239275575488
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.002590599	0.09703239275575488
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002590599	0.09703239275575488
ADAMS-OLIVER SYNDROME 5; AOS5	0.002590599	0.09703239275575488
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.002590599	0.09703239275575488
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.002590599	0.09703239275575488
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.09703239275575488
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.002590599	0.09703239275575488
SWEENEY-COX SYNDROME; SWCOS	0.0025101940000000003	0.09402077670111793
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.09402077670111793
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0025101940000000003	0.09402077670111793
GOLDBERG-SHPRINTZEN SYNDROME	0.0025101940000000003	0.09402077670111793
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0025101940000000003	0.09402077670111793
HURLER SYNDROME	0.0025101940000000003	0.09402077670111793
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0025101940000000003	0.09402077670111793
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.09402077670111793
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0025101940000000003	0.09402077670111793
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.0025101940000000003	0.09402077670111793
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0025101940000000003	0.09402077670111793
8Q22.1 MICRODELETION SYNDROME	0.0025101940000000003	0.09402077670111793
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0025101940000000003	0.09402077670111793
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0025101940000000003	0.09402077670111793
TREACHER-COLLINS SYNDROME	0.0025101940000000003	0.09402077670111793
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0025101940000000003	0.09402077670111793
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.09402077670111793
CHROMOSOME 18P DELETION SYNDROME	0.0025101940000000003	0.09402077670111793
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0025101940000000003	0.09402077670111793
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.09402077670111793
GERMAN SYNDROME	0.0025101940000000003	0.09402077670111793
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.09402077670111793
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.09402077670111793
TARP SYNDROME; TARPS	0.0025101940000000003	0.09402077670111793
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.09386589787037453
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.09386589787037453
ACROCARDIOFACIAL SYNDROME	0.002506059	0.09386589787037453
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.002506059	0.09386589787037453
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.09386589787037453
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002506059	0.09386589787037453
SPINOCEREBELLAR ATAXIA 47; SCA47	0.002506059	0.09386589787037453
17Q24.2 MICRODELETION SYNDROME	0.002506059	0.09386589787037453
PITT-HOPKINS SYNDROME	0.002506059	0.09386589787037453
FRYNS SYNDROME; FRNS	0.002506059	0.09386589787037453
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.002506059	0.09386589787037453
SIALIDOSIS TYPE 1	0.002506059	0.09386589787037453
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.002506059	0.09386589787037453
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.09386589787037453
LISSENCEPHALY, X-LINKED, 2	0.002506059	0.09386589787037453
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.002506059	0.09386589787037453
ZLOTOGORA-OGUR SYNDROME	0.002506059	0.09386589787037453
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002506059	0.09386589787037453
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.002506059	0.09386589787037453
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.002506059	0.09386589787037453
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.002506059	0.09386589787037453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.002506059	0.09386589787037453
GLUTAMINE DEFICIENCY, CONGENITAL	0.002506059	0.09386589787037453
FILIPPI SYNDROME; FLPIS	0.002506059	0.09386589787037453
311450 PALLISTER W SYNDROME;;W SYNDROME	0.002506059	0.09386589787037453
ASPARTYLGLUCOSAMINURIA	0.002506059	0.09386589787037453
RING CHROMOSOME 10 SYNDROME	0.002506059	0.09386589787037453
COFS SYNDROME	0.002506059	0.09386589787037453
ZIMMERMANN-LABAND SYNDROME 1	0.002506059	0.09386589787037453
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.08153608217550888
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.08153608217550888
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0021768739999999996	0.08153608217550888
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0021768739999999996	0.08153608217550888
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.08153608217550888
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.08153608217550888
JOUBERT SYNDROME 14	0.0021768739999999996	0.08153608217550888
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.08153608217550888
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021768739999999996	0.08153608217550888
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.08153608217550888
HADZISELIMOVIC SYNDROME	0.0021768739999999996	0.08153608217550888
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.08153608217550888
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.08153608217550888
TOLUENE EMBRYOPATHY	0.0021768739999999996	0.08153608217550888
MONOSOMY 13Q34	0.0021768739999999996	0.08153608217550888
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021768739999999996	0.08153608217550888
WARSAW BREAKAGE SYNDROME; WABS	0.0021768739999999996	0.08153608217550888
FETAL HYDANTOIN SYNDROME	0.0021768739999999996	0.08153608217550888
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.08153608217550888
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0021768739999999996	0.08153608217550888
48,XYYY SYNDROME	0.0021768739999999996	0.08153608217550888
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.08153608217550888
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0021768739999999996	0.08153608217550888
ROTHMUND-THOMSON SYNDROME	0.0021768739999999996	0.08153608217550888
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.08153608217550888
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.08153608217550888
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.08153608217550888
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.08153608217550888
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0021768739999999996	0.08153608217550888
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021768739999999996	0.08153608217550888
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021768739999999996	0.08153608217550888
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0021768739999999996	0.08153608217550888
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.08153608217550888
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.08153608217550888
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.08153608217550888
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021768739999999996	0.08153608217550888
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.08153608217550888
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0021768739999999996	0.08153608217550888
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.08153608217550888
16P11.2P12.2 MICRODELETION SYNDROME	0.0021768739999999996	0.08153608217550888
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021768739999999996	0.08153608217550888
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.08153608217550888
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.08153608217550888
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021768739999999996	0.08153608217550888
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.08153608217550888
ICF SYNDROME	0.0021768739999999996	0.08153608217550888
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.08153608217550888
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021768739999999996	0.08153608217550888
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.08153608217550888
LATERAL MENINGOCELE SYNDROME	0.0021768739999999996	0.08153608217550888
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0021768739999999996	0.08153608217550888
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002172739	0.08138120334476548
TETRASOMY 18P	0.002172739	0.08138120334476548
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002172739	0.08138120334476548
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.002172739	0.08138120334476548
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.08138120334476548
MARDEN-WALKER SYNDROME	0.002172739	0.08138120334476548
KNOBLOCH SYNDROME	0.002172739	0.08138120334476548
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002172739	0.08138120334476548
MOMO SYNDROME	0.002172739	0.08138120334476548
CHROMOSOME 18Q DELETION SYNDROME	0.002172739	0.08138120334476548
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002172739	0.08138120334476548
MECKEL SYNDROME, TYPE 10; MKS10	0.002172739	0.08138120334476548
CHIME SYNDROME	0.002172739	0.08138120334476548
OCULODENTODIGITAL DYSPLASIA; ODDD	0.002172739	0.08138120334476548
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002172739	0.08138120334476548
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.002172739	0.08138120334476548
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.002172739	0.08138120334476548
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.08138120334476548
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.08138120334476548
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.07675322911312704
SMITH-MAGENIS SYNDROME	0.00204918	0.07675322911312704
GREENBERG DYSPLASIA	0.00204918	0.07675322911312704
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.07675322911312704
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.07675322911312704
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.07675322911312704
EMERY-NELSON SYNDROME	0.00204918	0.07675322911312704
HEART-HAND SYNDROME TYPE 2	0.00204918	0.07675322911312704
SYMPHALANGISM, DISTAL	0.00204918	0.07675322911312704
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.07675322911312704
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.07675322911312704
2Q37 MONOSOMY	0.00204918	0.07675322911312704
SYNDACTYLY, TYPE V	0.00204918	0.07675322911312704
PSEUDOACHONDROPLASIA	0.00204918	0.07675322911312704
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.07675322911312704
CARPENTER SYNDROME	0.00204918	0.07675322911312704
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.07675322911312704
HEART-HAND SYNDROME TYPE 3	0.00204918	0.07675322911312704
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.07675322911312704
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312704
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.07675322911312704
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.07675322911312704
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.07675322911312704
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00204918	0.07675322911312704
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.07675322911312704
ACROMICRIC DYSPLASIA	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.07675322911312704
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.07675322911312704
BRACHYDACTYLY, TYPE E	0.00204918	0.07675322911312704
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.07675322911312704
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.07675322911312704
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.07675322911312704
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.07675322911312704
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00204918	0.07675322911312704
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.07675322911312704
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.07675322911312704
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312704
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00204918	0.07675322911312704
CLEIDOCRANIAL DYSPLASIA; CCD	0.00204918	0.07675322911312704
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00204918	0.07675322911312704
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.07675322911312704
COOKS SYNDROME	0.00204918	0.07675322911312704
ENG-STROM SYNDROME	0.00204918	0.07675322911312704
SHORT RIB-POLYDACTYLY SYNDROME	0.00204918	0.07675322911312704
PYCNODYSOSTOSIS	0.00204918	0.07675322911312704
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.07675322911312704
LOWRY-WOOD SYNDROME	0.00204918	0.07675322911312704
METATROPIC DYSPLASIA	0.00204918	0.07675322911312704
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.07675322911312704
ATELOSTEOGENESIS TYPE I	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.07675322911312704
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00204918	0.07675322911312704
JEUNE SYNDROME	0.00204918	0.07675322911312704
HYPOCHONDROPLASIA	0.00204918	0.07675322911312704
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00204918	0.07675322911312704
AREDYLD SYNDROME	0.00204918	0.07675322911312704
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.07675322911312704
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.07675322911312704
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00204918	0.07675322911312704
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.07675322911312704
SATOYOSHI SYNDROME	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.07675322911312704
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.07675322911312704
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.07675322911312704
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.07675322911312704
PYCNODYSOSTOSIS	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.07675322911312704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00204918	0.07675322911312704
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.07675322911312704
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.07675322911312704
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.07675322911312704
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.07675322911312704
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00204918	0.07675322911312704
ISOLATED BRACHYCEPHALY	0.00204918	0.07675322911312704
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.07675322911312704
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.07675322911312704
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00204918	0.07675322911312704
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00204918	0.07675322911312704
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.07675322911312704
LARON SYNDROME	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.07675322911312704
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.07675322911312704
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME	0.00204918	0.07675322911312704
PELVISCAPULAR DYSPLASIA	0.00204918	0.07675322911312704
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.07675322911312704
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.07675322911312704
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.07675322911312704
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.07675322911312704
EIKEN SYNDROME	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.07675322911312704
FGFR2-RELATED BENT BONE DYSPLASIA	0.00204918	0.07675322911312704
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.07675322911312704
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.07675322911312704
LETHAL KNIEST-LIKE DYSPLASIA	0.00204918	0.07675322911312704
OPSISMODYSPLASIA	0.00204918	0.07675322911312704
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00204918	0.07675322911312704
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.07675322911312704
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00204918	0.07675322911312704
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312704
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME 2	0.00204918	0.07675322911312704
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.07675322911312704
RIN2 SYNDROME	0.00204918	0.07675322911312704
MAL DE MELEDA	0.00204918	0.07675322911312704
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00204918	0.07675322911312704
RADIO-RENAL SYNDROME	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.07675322911312704
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.07675322911312704
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.07675322911312704
HYPOCHONDROPLASIA	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.07675322911312704
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.07675322911312704
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00204918	0.07675322911312704
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312704
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.07675322911312704
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.07675322911312704
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312704
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.07675322911312704
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00204918	0.07675322911312704
CHITAYAT SYNDROME	0.00204918	0.07675322911312704
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.07675322911312704
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00204918	0.07675322911312704
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.07675322911312704
MACS SYNDROME	0.00204918	0.07675322911312704
INFANTILE SYSTEMIC HYALINOSIS	0.00204918	0.07675322911312704
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.07675322911312704
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00204918	0.07675322911312704
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.07675322911312704
DESBUQUOIS DYSPLASIA 1	0.00204918	0.07675322911312704
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.07675322911312704
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.07675322911312704
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.07675322911312704
FOCAL DERMAL HYPOPLASIA; FDH	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00204918	0.07675322911312704
RHYNS SYNDROME; RHYNS	0.00204918	0.07675322911312704
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.07675322911312704
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.07675322911312704
GRANGE SYNDROME; GRNG	0.00204918	0.07675322911312704
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.07675322911312704
CHST3-RELATED SKELETAL DYSPLASIA	0.00204918	0.07675322911312704
LERI PLEONOSTEOSIS	0.00204918	0.07675322911312704
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.07358673422774667
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00196464	0.07358673422774667
OTOPALATODIGITAL SYNDROME TYPE 1	0.00196464	0.07358673422774667
FRONTOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774667
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.07358673422774667
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00196464	0.07358673422774667
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.07358673422774667
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00196464	0.07358673422774667
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00196464	0.07358673422774667
SIMOSA CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774667
WAARDENBURG SYNDROME	0.00196464	0.07358673422774667
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00196464	0.07358673422774667
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774667
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00196464	0.07358673422774667
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00196464	0.07358673422774667
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00196464	0.07358673422774667
MARSHALL SYNDROME	0.00196464	0.07358673422774667
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00196464	0.07358673422774667
COG1-CDG	0.00196464	0.07358673422774667
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.07358673422774667
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.07358673422774667
WAARDENBURG-SHAH SYNDROME	0.00196464	0.07358673422774667
ISOLATED TRIGONOCEPHALY	0.00196464	0.07358673422774667
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00196464	0.07358673422774667
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.07358673422774667
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00196464	0.07358673422774667
MULIBREY NANISM	0.00196464	0.07358673422774667
BRANCHIO-OCULO-FACIAL SYNDROME	0.00196464	0.07358673422774667
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.07358673422774667
TRISOMY 18-LIKE SYNDROME	0.00196464	0.07358673422774667
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00196464	0.07358673422774667
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00196464	0.07358673422774667
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.07358673422774667
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.07358673422774667
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774667
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.07358673422774667
ADULT SYNDROME	0.00196464	0.07358673422774667
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.07358673422774667
SCLEROSTEOSIS 1; SOST1	0.00196464	0.07358673422774667
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00196464	0.07358673422774667
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00196464	0.07358673422774667
JUNG SYNDROME	0.00196464	0.07358673422774667
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.07358673422774667
NEONATAL MARFAN SYNDROME	0.00196464	0.07358673422774667
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.07358673422774667
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00196464	0.07358673422774667
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.07358673422774667
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00196464	0.07358673422774667
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774667
BOOMERANG DYSPLASIA	0.00196464	0.07358673422774667
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.07358673422774667
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.07358673422774667
RETINITIS PIGMENTOSA	0.00196464	0.07358673422774667
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.07358673422774667
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774667
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00196464	0.07358673422774667
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00196464	0.07358673422774667
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.07358673422774667
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00196464	0.07358673422774667
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00196464	0.07358673422774667
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00196464	0.07358673422774667
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.07358673422774667
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00196464	0.07358673422774667
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.07358673422774667
STROMME SYNDROME; STROMS	0.00196464	0.07358673422774667
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.07358673422774667
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774667
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00196464	0.07358673422774667
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774667
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00196464	0.07358673422774667
MEGALENCEPHALY	0.00196464	0.07358673422774667
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.07358673422774667
BARBER-SAY SYNDROME	0.00196464	0.07358673422774667
SHELDON-HALL SYNDROME	0.00196464	0.07358673422774667
MOSAIC TRISOMY 1	0.00196464	0.07358673422774667
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00196464	0.07358673422774667
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.07358673422774667
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00196464	0.07358673422774667
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.07358673422774667
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00196464	0.07358673422774667
FRASER SYNDROME	0.00196464	0.07358673422774667
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774667
TRISOMY 18P	0.00196464	0.07358673422774667
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774667
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.07358673422774667
EPICANTHUS	0.00163132	0.06110203970213764
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00163132	0.06110203970213764
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.06110203970213764
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.06110203970213764
BRADDOCK SYNDROME	0.00163132	0.06110203970213764
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00163132	0.06110203970213764
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.06110203970213764
FETAL VALPROATE SYNDROME	0.00163132	0.06110203970213764
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.06110203970213764
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.06110203970213764
MYOTONIA PERMANENS	0.00163132	0.06110203970213764
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00163132	0.06110203970213764
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.06110203970213764
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00163132	0.06110203970213764
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.06110203970213764
LEGIUS SYNDROME	0.00163132	0.06110203970213764
COSTELLO SYNDROME	0.00163132	0.06110203970213764
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.06110203970213764
STICKLER SYNDROME	0.00163132	0.06110203970213764
SCARF SYNDROME	0.00163132	0.06110203970213764
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.06110203970213764
NOONAN SYNDROME 8; NS8	0.00163132	0.06110203970213764
TRISOMY XQ28	0.00163132	0.06110203970213764
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.06110203970213764
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.06110203970213764
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.06110203970213764
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.06110203970213764
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00163132	0.06110203970213764
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.06110203970213764
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.06110203970213764
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.06110203970213764
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213764
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.06110203970213764
PHAVER SYNDROME	0.00163132	0.06110203970213764
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.06110203970213764
EHLERS-DANLOS SYNDROME, TYPE I	0.00163132	0.06110203970213764
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.06110203970213764
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00163132	0.06110203970213764
ACROOTOOCULAR SYNDROME	0.00163132	0.06110203970213764
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00163132	0.06110203970213764
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00163132	0.06110203970213764
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.06110203970213764
BALLER-GEROLD SYNDROME	0.00163132	0.06110203970213764
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.06110203970213764
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.06110203970213764
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00163132	0.06110203970213764
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.06110203970213764
SCHOLTE SYNDROME; SHLTS	0.00163132	0.06110203970213764
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.06110203970213764
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.06110203970213764
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.06110203970213764
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.06110203970213764
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.06110203970213764
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.06110203970213764
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.06110203970213764
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.06110203970213764
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.06110203970213764
MARTSOLF SYNDROME	0.00163132	0.06110203970213764
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.06110203970213764
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.06110203970213764
BRITTLE CORNEA SYNDROME	0.00163132	0.06110203970213764
LICHTENSTEIN SYNDROME	0.00163132	0.06110203970213764
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.06110203970213764
EHLERS-DANLOS SYNDROME, TYPE VI	0.00163132	0.06110203970213764
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.06110203970213764
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.06110203970213764
JUBERG-MARSIDI SYNDROME	0.00163132	0.06110203970213764
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00163132	0.06110203970213764
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.06110203970213764
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213764
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.06110203970213764
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.06110203970213764
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00163132	0.06110203970213764
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.06110203970213764
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00163132	0.06110203970213764
14Q11.2 MICRODELETION SYNDROME	0.00163132	0.06110203970213764
MILROY DISEASE	0.00163132	0.06110203970213764
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.06110203970213764
PTERYGIUM COLLI, ISOLATED	0.00163132	0.06110203970213764
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.06110203970213764
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.06110203970213764
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.06110203970213764
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.06110203970213764
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00163132	0.06110203970213764
RING CHROMOSOME 8 SYNDROME	0.00163132	0.06110203970213764
MUCOLIPIDOSIS TYPE II	0.00163132	0.06110203970213764
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.0407132061159991
MEND SYNDROME	0.001086973	0.0407132061159991
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001086973	0.0407132061159991
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.0407132061159991
JOUBERT SYNDROME WITH RENAL DEFECT	0.001086973	0.0407132061159991
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
NARP SYNDROME	0.001086973	0.0407132061159991
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.0407132061159991
EAST SYNDROME	0.001086973	0.0407132061159991
PITT-HOPKINS SYNDROME	0.001086973	0.0407132061159991
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.0407132061159991
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.0407132061159991
SRD5A3-CDG	0.001086973	0.0407132061159991
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001086973	0.0407132061159991
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.0407132061159991
15Q14 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
GRISCELLI SYNDROME	0.001086973	0.0407132061159991
ALSTRÖM SYNDROME	0.001086973	0.0407132061159991
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.0407132061159991
WILSON-TURNER SYNDROME	0.001086973	0.0407132061159991
MEVALONIC ACIDURIA	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.0407132061159991
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.0407132061159991
HARTNUP DISEASE	0.001086973	0.0407132061159991
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.0407132061159991
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.0407132061159991
DONNAI-BARROW SYNDROME	0.001086973	0.0407132061159991
LEBER CONGENITAL AMAUROSIS	0.001086973	0.0407132061159991
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.0407132061159991
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.0407132061159991
PHACE SYNDROME	0.001086973	0.0407132061159991
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
ISOVALERIC ACIDEMIA	0.001086973	0.0407132061159991
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.0407132061159991
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.0407132061159991
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.0407132061159991
HYDRANENCEPHALY	0.001086973	0.0407132061159991
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.0407132061159991
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001086973	0.0407132061159991
NETHERTON SYNDROME	0.001086973	0.0407132061159991
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
DYSTONIA-APHONIA SYNDROME	0.001086973	0.0407132061159991
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.0407132061159991
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.0407132061159991
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.0407132061159991
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.0407132061159991
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.0407132061159991
CITRULLINEMIA TYPE II	0.001086973	0.0407132061159991
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.0407132061159991
WYBURN-MASON SYNDROME	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.0407132061159991
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.0407132061159991
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.0407132061159991
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.0407132061159991
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.0407132061159991
GALACTOSEMIA	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.0407132061159991
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.0407132061159991
L1 SYNDROME	0.001086973	0.0407132061159991
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.0407132061159991
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.0407132061159991
CEDNIK SYNDROME	0.001086973	0.0407132061159991
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.0407132061159991
JOUBERT SYNDROME	0.001086973	0.0407132061159991
RFT1-CDG	0.001086973	0.0407132061159991
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.0407132061159991
STT3A-CDG	0.001086973	0.0407132061159991
CRANIOPHARYNGIOMA	0.001086973	0.0407132061159991
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001086973	0.0407132061159991
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.0407132061159991
KBG SYNDROME	0.001086973	0.0407132061159991
SSR4-CDG	0.001086973	0.0407132061159991
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.0407132061159991
STT3B-CDG	0.001086973	0.0407132061159991
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.0407132061159991
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.0407132061159991
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.0407132061159991
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.0407132061159991
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
MAPLE SYRUP URINE DISEASE	0.001086973	0.0407132061159991
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.0407132061159991
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.0407132061159991
SEVERE CANAVAN DISEASE	0.001086973	0.0407132061159991
INCONTINENTIA PIGMENTI	0.001086973	0.0407132061159991
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.0407132061159991
ALG11-CDG	0.001086973	0.0407132061159991
XP21 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.0407132061159991
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.0407132061159991
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.0407132061159991
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.0407132061159991
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.0407132061159991
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.0407132061159991
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.0407132061159991
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.0407132061159991
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.0407132061159991
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.0407132061159991
SCHIZENCEPHALY	0.001086973	0.0407132061159991
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.0407132061159991
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.0407132061159991
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.0407132061159991
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.0407132061159991
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.0407132061159991
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.0407132061159991
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.0407132061159991
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.0407132061159991
CODAS SYNDROME	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.0407132061159991
WALKER-WARBURG SYNDROME	0.001086973	0.0407132061159991
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.0407132061159991
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.0407132061159991
ARGININEMIA	0.001086973	0.0407132061159991
TIMOTHY SYNDROME; TS	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.0407132061159991
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.0407132061159991
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.0407132061159991
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.0407132061159991
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.0407132061159991
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.0407132061159991
WAISMAN SYNDROME; WSMN	0.001086973	0.0407132061159991
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.0407132061159991
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.0407132061159991
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
MEND SYNDROME; MEND	0.001086973	0.0407132061159991
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 5	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.0407132061159991
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.0407132061159991
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.0407132061159991
SULFOCYSTEINURIA	0.001086973	0.0407132061159991
MIRAGE SYNDROME; MIRAGE	0.001086973	0.0407132061159991
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.0407132061159991
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.0407132061159991
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.0407132061159991
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.0407132061159991
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.0407132061159991
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.0407132061159991
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.0407132061159991
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.0407132061159991
ALG1-CDG	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.0407132061159991
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.0407132061159991
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.0407132061159991
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.0407132061159991
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.0407132061159991
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.0407132061159991
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.0407132061159991
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.0407132061159991
GRISCELLI SYNDROME TYPE 1	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.0407132061159991
PFEIFFER SYNDROME TYPE 2	0.001086973	0.0407132061159991
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.0407132061159991
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.0407132061159991
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001086973	0.0407132061159991
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.0407132061159991
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.0407132061159991
MEHMO SYNDROME; MEHMO	0.001086973	0.0407132061159991
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.0407132061159991
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.0407132061159991
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.0407132061159991
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.0407132061159991
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.001086973	0.0407132061159991
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.0407132061159991
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.0407132061159991
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.0407132061159991
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.0407132061159991
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.0407132061159991
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.0407132061159991
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.0407132061159991
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.0407132061159991
KEUTEL SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.0407132061159991
LISSENCEPHALY 4	0.001086973	0.0407132061159991
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.0407132061159991
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.0407132061159991
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.0407132061159991
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.0407132061159991
GENITOPATELLAR SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.0407132061159991
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.0407132061159991
EMANUEL SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001086973	0.0407132061159991
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.0407132061159991
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.0407132061159991
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.0407132061159991
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.0407132061159991
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.0407132061159991
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.0407132061159991
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.0407132061159991
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 7	0.001086973	0.0407132061159991
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.0407132061159991
GLASS SYNDROME	0.001086973	0.0407132061159991
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.0407132061159991
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.0407132061159991
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.0407132061159991
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.0407132061159991
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.0407132061159991
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.0407132061159991
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.0407132061159991
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.0407132061159991
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.0407132061159991
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.0407132061159991
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001086973	0.0407132061159991
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.0407132061159991
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.0407132061159991
PHACE ASSOCIATION	0.001086973	0.0407132061159991
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.0407132061159991
PROPIONIC ACIDEMIA	0.001086973	0.0407132061159991
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.0407132061159991
FREE SIALIC ACID STORAGE DISEASE	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.0407132061159991
SALLA DISEASE	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.0407132061159991
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.0407132061159991
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.0407132061159991
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.0407132061159991
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.0407132061159991
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.0407132061159991
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.0407132061159991
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.0407132061159991
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.0407132061159991
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.0407132061159991
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.0407132061159991
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.0407132061159991
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.0407132061159991
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.0407132061159991
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.0407132061159991
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.0407132061159991
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.0407132061159991
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.0407132061159991
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.0407132061159991
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.0407132061159991
SIALIDOSIS TYPE 2	0.001086973	0.0407132061159991
LISSENCEPHALY 1; LIS1	0.001086973	0.0407132061159991
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.0407132061159991
LISSENCEPHALY 8; LIS8	0.001086973	0.0407132061159991
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.0407132061159991
HARTNUP DISORDER	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.0407132061159991
DIGEORGE SYNDROME; DGS	0.001086973	0.0407132061159991
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.001086973	0.0407132061159991
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.0407132061159991
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.0407132061159991
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.0407132061159991
VICI SYNDROME; VICIS	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.0407132061159991
ARGININOSUCCINIC ACIDURIA	0.001086973	0.0407132061159991
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.0407132061159991
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.0407132061159991
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001086973	0.0407132061159991
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.0407132061159991
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.0407132061159991
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.0407132061159991
INFANTILE REFSUM DISEASE	0.001086973	0.0407132061159991
KETOADIPICACIDURIA	0.001086973	0.0407132061159991
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.0407132061159991
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.0407132061159991
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.0407132061159991
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.0407132061159991
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.0407132061159991
MACDERMOT-WINTER SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.0407132061159991
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.0407132061159991
LANDAU-KLEFFNER SYNDROME	0.001086973	0.0407132061159991
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.0407132061159991
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.0407132061159991
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.0407132061159991
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.0407132061159991
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.0407132061159991
GAUCHER DISEASE, TYPE II	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.0407132061159991
DISTAL MONOSOMY 19P13.3	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.0407132061159991
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.0407132061159991
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.0407132061159991
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.0407132061159991
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.0407132061159991
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.0407132061159991
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.0407132061159991
COACH SYNDROME	0.001086973	0.0407132061159991
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.0407132061159991
CLASSIC PHENYLKETONURIA	0.001086973	0.0407132061159991
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.0407132061159991
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.0407132061159991
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.0407132061159991
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.0407132061159991
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.0407132061159991
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.0407132061159991
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.0407132061159991
CITRULLINEMIA, CLASSIC	0.001086973	0.0407132061159991
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.0407132061159991
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.0407132061159991
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.0407132061159991
KBG SYNDROME	0.001086973	0.0407132061159991
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.0407132061159991
PALLISTER-HALL SYNDROME	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.0407132061159991
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.0407132061159991
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.0407132061159991
VICI SYNDROME	0.001086973	0.0407132061159991
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.0407132061159991
ALG3-CDG	0.001086973	0.0407132061159991
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.0407132061159991
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.0407132061159991
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.0407132061159991
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.0407132061159991
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.0407132061159991
2P21 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
ELEJALDE DISEASE	0.001086973	0.0407132061159991
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.0407132061159991
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.0407132061159991
DISTAL MONOSOMY 15Q	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.0407132061159991
COFFIN-SIRIS SYNDROME 1; CSS1	0.001086973	0.0407132061159991
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.0407132061159991
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.0407132061159991
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.0407132061159991
LEIGH SYNDROME; LS	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.0407132061159991
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.0407132061159991
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.0407132061159991
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.0407132061159991
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.0407132061159991
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.0407132061159991
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001086973	0.0407132061159991
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.0407132061159991
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.0407132061159991
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.0407132061159991
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001086973	0.0407132061159991
ANGELMAN SYNDROME	0.001086973	0.0407132061159991
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.0407132061159991
XQ21 MICRODELETION SYNDROME	0.001086973	0.0407132061159991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.0407132061159991
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.0407132061159991
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.0407132061159991
XQ28 (MECP2) DUPLICATION	0.001086973	0.0407132061159991
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.0407132061159991
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.0407132061159991
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.020434042473371255
JOUBERT SYNDROME 6	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020434042473371255
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.020434042473371255
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020434042473371255
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.020434042473371255
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020434042473371255
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020434042473371255
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.020434042473371255
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020434042473371255
HURLER SYNDROME	0.000545554	0.020434042473371255
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.020434042473371255
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.020434042473371255
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.020434042473371255
SENIOR-LOKEN SYNDROME	0.000545554	0.020434042473371255
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.020434042473371255
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.020434042473371255
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.020434042473371255
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020434042473371255
FRIED SYNDROME	0.000545554	0.020434042473371255
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.020434042473371255
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020434042473371255
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020434042473371255
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.020434042473371255
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.020434042473371255
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.020434042473371255
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020434042473371255
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020434042473371255
SEPTOOPTIC DYSPLASIA	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.020434042473371255
LIG4 SYNDROME	0.000545554	0.020434042473371255
FRIAS SYNDROME	0.000545554	0.020434042473371255
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020434042473371255
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020434042473371255
CURRARINO SYNDROME	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020434042473371255
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020434042473371255
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.020434042473371255
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020434042473371255
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020434042473371255
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.020434042473371255
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020434042473371255
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020434042473371255
ALSTROM SYNDROME; ALMS	0.000545554	0.020434042473371255
ABETAL34V AMYLOIDOSIS	0.000545554	0.020434042473371255
MEVALONIC ACIDURIA; MEVA	0.000545554	0.020434042473371255
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020434042473371255
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.020434042473371255
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.020434042473371255
JOUBERT SYNDROME 2	0.000545554	0.020434042473371255
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020434042473371255
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.020434042473371255
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020434042473371255
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020434042473371255
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020434042473371255
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.020434042473371255
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.020434042473371255
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.020434042473371255
RIGID SPINE SYNDROME	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020434042473371255
AUSTRALIA ANTIGEN	0.000545554	0.020434042473371255
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020434042473371255
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.020434042473371255
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020434042473371255
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020434042473371255
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020434042473371255
PELLAGRA-LIKE SYNDROME	0.000545554	0.020434042473371255
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.020434042473371255
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.020434042473371255
WAARDENBURG-SHAH SYNDROME	0.000545554	0.020434042473371255
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020434042473371255
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020434042473371255
JOUBERT SYNDROME 7	0.000545554	0.020434042473371255
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020434042473371255
300270 ADRENOMYODYSTROPHY	0.000545554	0.020434042473371255
JAWAD SYNDROME	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020434042473371255
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020434042473371255
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020434042473371255
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.020434042473371255
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020434042473371255
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.020434042473371255
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.020434042473371255
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020434042473371255
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.020434042473371255
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.020434042473371255
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020434042473371255
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.020434042473371255
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020434042473371255
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.020434042473371255
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020434042473371255
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020434042473371255
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020434042473371255
MUCOLIPIDOSIS IV; ML4	0.000545554	0.020434042473371255
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.020434042473371255
OROTIC ACIDURIA	0.000545554	0.020434042473371255
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020434042473371255
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020434042473371255
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020434042473371255
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.020434042473371255
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.020434042473371255
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020434042473371255
NAVAJO NEUROHEPATOPATHY	0.000545554	0.020434042473371255
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020434042473371255
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.020434042473371255
REVESZ SYNDROME	0.000545554	0.020434042473371255
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.020434042473371255
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020434042473371255
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020434042473371255
NETHERTON SYNDROME; NETH	0.000545554	0.020434042473371255
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020434042473371255
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020434042473371255
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020434042473371255
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020434042473371255
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020434042473371255
RIDDLE SYNDROME	0.000545554	0.020434042473371255
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020434042473371255
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020434042473371255
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020434042473371255
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020434042473371255
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020434042473371255
CURRY-JONES SYNDROME	0.000545554	0.020434042473371255
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020434042473371255
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.020434042473371255
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020434042473371255
CDAGS SYNDROME	0.000545554	0.020434042473371255
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.020434042473371255
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020434042473371255
CONGENITAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
FARBER DISEASE	0.000545554	0.020434042473371255
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.020434042473371255
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.020434042473371255
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.020434042473371255
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020434042473371255
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020434042473371255
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020434042473371255
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020434042473371255
NOONAN SYNDROME 2; NS2	0.000545554	0.020434042473371255
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020434042473371255
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020434042473371255
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020434042473371255
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020434042473371255
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020434042473371255
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020434042473371255
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.020434042473371255
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020434042473371255
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.020434042473371255
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020434042473371255
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020434042473371255
THYROID ECTOPIA	0.000545554	0.020434042473371255
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.020434042473371255
EPIDERMAL NEVUS SYNDROME	0.000545554	0.020434042473371255
ATHYREOSIS	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.020434042473371255
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020434042473371255
ARIMA SYNDROME	0.000545554	0.020434042473371255
PROPIONIC ACIDEMIA	0.000545554	0.020434042473371255
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.020434042473371255
YUNIS-VARON SYNDROME	0.000545554	0.020434042473371255
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.020434042473371255
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020434042473371255
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.020434042473371255
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020434042473371255
THYROID HEMIAGENESIS	0.000545554	0.020434042473371255
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020434042473371255
LOWRY-MACLEAN SYNDROME	0.000545554	0.020434042473371255
WEAVER SYNDROME	0.000545554	0.020434042473371255
THYROID HYPOPLASIA	0.000545554	0.020434042473371255
HYDROXYKYNURENINURIA	0.000545554	0.020434042473371255
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020434042473371255
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020434042473371255
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020434042473371255
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.020434042473371255
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.020434042473371255
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020434042473371255
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020434042473371255
OPTIC ATROPHY 11; OPA11	0.000545554	0.020434042473371255
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.020434042473371255
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020434042473371255
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.020434042473371255
ALAZAMI-YUAN SYNDROME	0.000545554	0.020434042473371255
JOUBERT SYNDROME 28	0.000545554	0.020434042473371255
JOUBERT SYNDROME 27	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020434042473371255
MEIER-GORLIN SYNDROME 7	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020434042473371255
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020434042473371255
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
MARDEN-WALKER SYNDROME	0.000545554	0.020434042473371255
ALG6-CDG	0.000545554	0.020434042473371255
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.020434042473371255
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020434042473371255
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020434042473371255
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.020434042473371255
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020434042473371255
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.020434042473371255
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.020434042473371255
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020434042473371255
MEDULLOBLASTOMA	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020434042473371255
MECKEL SYNDROME 13; MKS13	0.000545554	0.020434042473371255
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.020434042473371255
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020434042473371255
RAHMAN SYNDROME	0.000545554	0.020434042473371255
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.020434042473371255
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020434042473371255
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020434042473371255
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.020434042473371255
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020434042473371255
NOONAN SYNDROME 9; NS9	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020434042473371255
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020434042473371255
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020434042473371255
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.020434042473371255
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020434042473371255
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020434042473371255
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020434042473371255
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020434042473371255
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020434042473371255
JOUBERT SYNDROME 24	0.000545554	0.020434042473371255
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020434042473371255
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.020434042473371255
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.020434042473371255
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020434042473371255
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.020434042473371255
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020434042473371255
JOUBERT SYNDROME 26	0.000545554	0.020434042473371255
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.020434042473371255
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020434042473371255
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020434042473371255
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020434042473371255
ATELOSTEOGENESIS TYPE III	0.000545554	0.020434042473371255
N SYNDROME	0.000545554	0.020434042473371255
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020434042473371255
USHER SYNDROME TYPE 1	0.000545554	0.020434042473371255
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020434042473371255
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.020434042473371255
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020434042473371255
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020434042473371255
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020434042473371255
TRANSALDOLASE DEFICIENCY	0.000545554	0.020434042473371255
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020434042473371255
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.020434042473371255
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.020434042473371255
NOONAN SYNDROME 11; NS11	0.000545554	0.020434042473371255
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.020434042473371255
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000545554	0.020434042473371255
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020434042473371255
COLE-CARPENTER SYNDROME	0.000545554	0.020434042473371255
RABSON-MENDENHALL SYNDROME	0.000545554	0.020434042473371255
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.020434042473371255
AURICULOCONDYLAR SYNDROME	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA	0.000545554	0.020434042473371255
DISTAL TRISOMY 6P	0.000545554	0.020434042473371255
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
DEXTROCARDIA	0.000545554	0.020434042473371255
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.020434042473371255
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020434042473371255
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.020434042473371255
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020434042473371255
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020434042473371255
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020434042473371255
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020434042473371255
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020434042473371255
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.020434042473371255
WOLMAN DISEASE	0.000545554	0.020434042473371255
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020434042473371255
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020434042473371255
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020434042473371255
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020434042473371255
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020434042473371255
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.020434042473371255
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020434042473371255
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.020434042473371255
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.020434042473371255
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.020434042473371255
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020434042473371255
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020434042473371255
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020434042473371255
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020434042473371255
HYPERTRICHOSIS CUBITI	0.000545554	0.020434042473371255
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.020434042473371255
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020434042473371255
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020434042473371255
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020434042473371255
HYDROXYKYNURENINURIA	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020434042473371255
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020434042473371255
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.020434042473371255
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.020434042473371255
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.020434042473371255
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.020434042473371255
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020434042473371255
JOUBERT SYNDROME 25	0.000545554	0.020434042473371255
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.020434042473371255
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.020434042473371255
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.020434042473371255
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.020434042473371255
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020434042473371255
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020434042473371255
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020434042473371255
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020434042473371255
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020434042473371255
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020434042473371255
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020434042473371255
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.020434042473371255
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020434042473371255
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020434042473371255
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020434042473371255
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020434042473371255
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020434042473371255
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.020434042473371255
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020434042473371255
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020434042473371255
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020434042473371255
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.020434042473371255
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020434042473371255
JOUBERT SYNDROME 15	0.000545554	0.020434042473371255
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020434042473371255
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020434042473371255
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020434042473371255
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.020434042473371255
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020434042473371255
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020434042473371255
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020434042473371255
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020434042473371255
JOUBERT SYNDROME 8	0.000545554	0.020434042473371255
OXOGLUTARIC ACIDURIA	0.000545554	0.020434042473371255
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.020434042473371255
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020434042473371255
SAY-BARBER-MILLER SYNDROME	0.000545554	0.020434042473371255
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020434042473371255
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020434042473371255
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020434042473371255
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.020434042473371255
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020434042473371255
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020434042473371255
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.020434042473371255
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.020434042473371255
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020434042473371255
HOLOPROSENCEPHALY 11	0.000545554	0.020434042473371255
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020434042473371255
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020434042473371255
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020434042473371255
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020434042473371255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020434042473371255
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020434042473371255
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020434042473371255
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.020434042473371255
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020434042473371255
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020434042473371255
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020434042473371255
TRANSKETOLASE DEFICIENCY	0.000545554	0.020434042473371255
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020434042473371255
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020434042473371255
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020434042473371255
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020434042473371255
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020434042473371255
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020434042473371255
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020434042473371255
XIA-GIBBS SYNDROME	0.000545554	0.020434042473371255
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.020434042473371255
CULLER-JONES SYNDROME; CJS	0.000545554	0.020434042473371255
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020434042473371255
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020434042473371255
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.020434042473371255
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020434042473371255
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 2	0.000545554	0.020434042473371255
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020434042473371255
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020434042473371255
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020434042473371255
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020434042473371255
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020434042473371255
JOUBERT SYNDROME 21	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020434042473371255
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.020434042473371255
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020434042473371255
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020434042473371255
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020434042473371255
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.020434042473371255
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020434042473371255
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020434042473371255
LASSA FEVER	0.000541419	0.020279163642627846
INSULINOMA	0.000541419	0.020279163642627846
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020279163642627846
ONDINE SYNDROME	0.000541419	0.020279163642627846
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020279163642627846
NIPAH VIRUS DISEASE	0.000541419	0.020279163642627846
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020279163642627846
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020279163642627846
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020279163642627846
47,XYY SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020279163642627846
WHIM SYNDROME	0.000541419	0.020279163642627846
SECONDARY SYRINGOMYELIA	0.000541419	0.020279163642627846
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020279163642627846
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020279163642627846
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020279163642627846
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.020279163642627846
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020279163642627846
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020279163642627846
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020279163642627846
SANDHOFF DISEASE	0.000541419	0.020279163642627846
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020279163642627846
PORPHYRIA	0.000541419	0.020279163642627846
SCLERODERMA	0.000541419	0.020279163642627846
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020279163642627846
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020279163642627846
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020279163642627846
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020279163642627846
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020279163642627846
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020279163642627846
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020279163642627846
RABIES	0.000541419	0.020279163642627846
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020279163642627846
FETAL GAUCHER DISEASE	0.000541419	0.020279163642627846
DERMOTRICHIC SYNDROME	0.000541419	0.020279163642627846
ANGELMAN SYNDROME	0.000541419	0.020279163642627846
MEHMO SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020279163642627846
ADRENOMYODYSTROPHY	0.000541419	0.020279163642627846
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020279163642627846
FRAGILE X SYNDROME	0.000541419	0.020279163642627846
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020279163642627846
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020279163642627846
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020279163642627846
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020279163642627846
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020279163642627846
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.020279163642627846
MYASTHENIA GRAVIS	0.000541419	0.020279163642627846
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020279163642627846
ALG2-CDG	0.000541419	0.020279163642627846
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.020279163642627846
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020279163642627846
MPDU1-CDG	0.000541419	0.020279163642627846
OCULOCEREBRORENAL SYNDROME OF LOWE	0.000541419	0.020279163642627846
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020279163642627846
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020279163642627846
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020279163642627846
DPM1-CDG	0.000541419	0.020279163642627846
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020279163642627846
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020279163642627846
CAMOS SYNDROME	0.000541419	0.020279163642627846
SCRUB TYPHUS	0.000541419	0.020279163642627846
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020279163642627846
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020279163642627846
PARTINGTON SYNDROME	0.000541419	0.020279163642627846
CENTRONUCLEAR MYOPATHY	0.000541419	0.020279163642627846
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020279163642627846
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020279163642627846
ISOLATED SPINA BIFIDA	0.000541419	0.020279163642627846
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020279163642627846
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020279163642627846
ENCEPHALITIS LETHARGICA	0.000541419	0.020279163642627846
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020279163642627846
SYSTEMIC SCLEROSIS	0.000541419	0.020279163642627846
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020279163642627846
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020279163642627846
LEIGH SYNDROME	0.000541419	0.020279163642627846
DEND SYNDROME	0.000541419	0.020279163642627846
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020279163642627846
EPISODIC ATAXIA TYPE 3	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020279163642627846
PORPHYRIA VARIEGATA	0.000541419	0.020279163642627846
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020279163642627846
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020279163642627846
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020279163642627846
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020279163642627846
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020279163642627846
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.020279163642627846
LIPOID PROTEINOSIS	0.000541419	0.020279163642627846
ADDISON DISEASE	0.000541419	0.020279163642627846
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020279163642627846
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020279163642627846
HEREDITARY COPROPORPHYRIA	0.000541419	0.020279163642627846
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020279163642627846
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020279163642627846
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.020279163642627846
MOGS-CDG	0.000541419	0.020279163642627846
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.020279163642627846
ALG9-CDG	0.000541419	0.020279163642627846
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020279163642627846
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020279163642627846
KALLMANN SYNDROME	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020279163642627846
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020279163642627846
CYCLIC VOMITING SYNDROME	0.000541419	0.020279163642627846
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020279163642627846
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020279163642627846
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020279163642627846
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020279163642627846
GURRIERI SYNDROME	0.000541419	0.020279163642627846
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020279163642627846
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020279163642627846
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627846
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020279163642627846
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020279163642627846
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020279163642627846
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020279163642627846
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020279163642627846
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020279163642627846
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627846
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020279163642627846
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020279163642627846
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020279163642627846
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020279163642627846
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020279163642627846
ALZHEIMER DISEASE 3; AD	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020279163642627846
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020279163642627846
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020279163642627846
ADRENOLEUKODYSTROPHY	0.000541419	0.020279163642627846
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020279163642627846
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020279163642627846
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020279163642627846
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020279163642627846
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020279163642627846
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020279163642627846
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 47	0.000541419	0.020279163642627846
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020279163642627846
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020279163642627846
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020279163642627846
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020279163642627846
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020279163642627846
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020279163642627846
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020279163642627846
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.020279163642627846
MENKES DISEASE	0.000541419	0.020279163642627846
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020279163642627846
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020279163642627846
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020279163642627846
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020279163642627846
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.000541419	0.020279163642627846
PERRAULT SYNDROME 3	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020279163642627846
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.020279163642627846
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020279163642627846
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020279163642627846
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020279163642627846
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020279163642627846
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020279163642627846
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020279163642627846
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020279163642627846
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020279163642627846
COWDEN SYNDROME 5; CWS5	0.000541419	0.020279163642627846
COWDEN SYNDROME 6; CWS6	0.000541419	0.020279163642627846
LISSENCEPHALY 5; LIS5	0.000541419	0.020279163642627846
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020279163642627846
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020279163642627846
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020279163642627846
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.020279163642627846
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020279163642627846
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020279163642627846
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020279163642627846
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020279163642627846
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020279163642627846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020279163642627846
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020279163642627846
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020279163642627846
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020279163642627846
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020279163642627846
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020279163642627846
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.020279163642627846
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020279163642627846
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020279163642627846
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020279163642627846
LISSENCEPHALY 3; LIS3	0.000541419	0.020279163642627846
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020279163642627846
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020279163642627846
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020279163642627846
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.020279163642627846
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020279163642627846
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020279163642627846
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.020279163642627846
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020279163642627846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020279163642627846
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020279163642627846
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.020279163642627846
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.020279163642627846
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020279163642627846
STURGE-WEBER SYNDROME	0.000541419	0.020279163642627846
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020279163642627846
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020279163642627846
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020279163642627846
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020279163642627846
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020279163642627846
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.020279163642627846
AUTISM	0.000541419	0.020279163642627846
BANGSTAD SYNDROME	0.000541419	0.020279163642627846
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020279163642627846
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020279163642627846
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020279163642627846
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020279163642627846
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020279163642627846
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020279163642627846
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020279163642627846
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020279163642627846
COCKAYNE SYNDROME A; CSA	0.000541419	0.020279163642627846
COHEN SYNDROME	0.000541419	0.020279163642627846
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020279163642627846
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020279163642627846
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020279163642627846
CROME SYNDROME	0.000541419	0.020279163642627846
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020279163642627846
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020279163642627846
DIAMINOPENTANURIA	0.000541419	0.020279163642627846
SNEDDON SYNDROME	0.000541419	0.020279163642627846
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020279163642627846
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020279163642627846
PARIETAL FORAMINA	0.000541419	0.020279163642627846
1P36 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020279163642627846
2Q33.1 DELETION SYNDROME	0.000541419	0.020279163642627846
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020279163642627846
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020279163642627846
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020279163642627846
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.020279163642627846
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020279163642627846
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020279163642627846
PAPILLORENAL SYNDROME	0.000541419	0.020279163642627846
CROUZON SYNDROME	0.000541419	0.020279163642627846
DARIER-WHITE DISEASE; DAR	0.000541419	0.020279163642627846
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020279163642627846
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020279163642627846
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020279163642627846
EPILEPSY, READING	0.000541419	0.020279163642627846
FLYNN-AIRD SYNDROME	0.000541419	0.020279163642627846
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020279163642627846
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020279163642627846
HUNTINGTON DISEASE; HD	0.000541419	0.020279163642627846
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020279163642627846
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020279163642627846
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020279163642627846
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020279163642627846
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020279163642627846
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020279163642627846
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020279163642627846
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020279163642627846
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020279163642627846
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020279163642627846
EPILEPSY-TELANGIECTASIA	0.000541419	0.020279163642627846
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020279163642627846
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020279163642627846
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020279163642627846
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020279163642627846
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020279163642627846
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020279163642627846
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020279163642627846
NEURAMINIDASE DEFICIENCY	0.000541419	0.020279163642627846
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020279163642627846
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020279163642627846
PHENYLKETONURIA	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020279163642627846
GITELMAN SYNDROME	0.000541419	0.020279163642627846
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020279163642627846
RAMON SYNDROME	0.000541419	0.020279163642627846
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020279163642627846
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020279163642627846
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020279163642627846
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020279163642627846
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020279163642627846
TAY-SACHS DISEASE; TSD	0.000541419	0.020279163642627846
THREONINEMIA	0.000541419	0.020279163642627846
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020279163642627846
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020279163642627846
XYLOSIDASE DEFICIENCY	0.000541419	0.020279163642627846
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020279163642627846
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020279163642627846
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.020279163642627846
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020279163642627846
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020279163642627846
FOUNTAIN SYNDROME	0.000541419	0.020279163642627846
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020279163642627846
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627846
GAPO SYNDROME; GAPOS	0.000541419	0.020279163642627846
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020279163642627846
BERNARD-SOULIER SYNDROME	0.000541419	0.020279163642627846
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020279163642627846
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020279163642627846
HYPER-BETA-ALANINEMIA	0.000541419	0.020279163642627846
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020279163642627846
HYPERLYSINEMIA, TYPE I	0.000541419	0.020279163642627846
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020279163642627846
HYPERPROLINEMIA, TYPE II	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020279163642627846
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020279163642627846
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020279163642627846
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020279163642627846
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020279163642627846
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020279163642627846
KAPUR-TORIELLO SYNDROME	0.000541419	0.020279163642627846
KEUTEL SYNDROME; KTLS	0.000541419	0.020279163642627846
KIFAFA SEIZURE DISORDER	0.000541419	0.020279163642627846
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020279163642627846
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020279163642627846
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020279163642627846
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020279163642627846
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020279163642627846
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020279163642627846
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020279163642627846
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020279163642627846
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020279163642627846
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020279163642627846
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020279163642627846
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020279163642627846
EPENDYMOMA	0.000541419	0.020279163642627846
SUBEPENDYMOMA	0.000541419	0.020279163642627846
PINEOBLASTOMA	0.000541419	0.020279163642627846
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.000541419	0.020279163642627846
MICROSPORIDIOSIS	0.000541419	0.020279163642627846
MOYAMOYA DISEASE	0.000541419	0.020279163642627846
MOYNAHAN SYNDROME	0.000541419	0.020279163642627846
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020279163642627846
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020279163642627846
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020279163642627846
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020279163642627846
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020279163642627846
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020279163642627846
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020279163642627846
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020279163642627846
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020279163642627846
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020279163642627846
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627846
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020279163642627846
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.020279163642627846
TYROSINEMIA TYPE 2	0.000541419	0.020279163642627846
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020279163642627846
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020279163642627846
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020279163642627846
EPISODIC ATAXIA TYPE 6	0.000541419	0.020279163642627846
HARROD SYNDROME	0.000541419	0.020279163642627846
CYSTATHIONINURIA	0.000541419	0.020279163642627846
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020279163642627846
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020279163642627846
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020279163642627846
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.000541419	0.020279163642627846
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020279163642627846
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020279163642627846
CONGENITAL HYDROCEPHALUS	0.000541419	0.020279163642627846
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020279163642627846
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020279163642627846
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020279163642627846
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020279163642627846
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020279163642627846
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020279163642627846
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020279163642627846
KABUKI SYNDROME	0.000541419	0.020279163642627846
SANJAD-SAKATI SYNDROME	0.000541419	0.020279163642627846
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020279163642627846
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020279163642627846
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627846
4Q21 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.000541419	0.020279163642627846
LOWRY-MACLEAN SYNDROME	0.000541419	0.020279163642627846
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020279163642627846
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020279163642627846
CRONKHITE-CANADA SYNDROME	0.000541419	0.020279163642627846
PORENCEPHALY	0.000541419	0.020279163642627846
PROLACTINOMA	0.000541419	0.020279163642627846
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020279163642627846
WORSTER-DROUGHT SYNDROME	0.000541419	0.020279163642627846
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020279163642627846
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627846
GALACTOSIALIDOSIS	0.000541419	0.020279163642627846
GM1 GANGLIOSIDOSIS	0.000541419	0.020279163642627846
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020279163642627846
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020279163642627846
GLIOBLASTOMA	0.000541419	0.020279163642627846
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020279163642627846
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020279163642627846
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020279163642627846
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020279163642627846
CLASSIC HOMOCYSTINURIA	0.000541419	0.020279163642627846
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020279163642627846
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020279163642627846
HYPERPROLINEMIA TYPE 1	0.000541419	0.020279163642627846
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020279163642627846
HYPOPHOSPHATASIA	0.000541419	0.020279163642627846
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020279163642627846
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020279163642627846
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020279163642627846
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020279163642627846
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020279163642627846
SLC39A8-CDG	0.000541419	0.020279163642627846
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020279163642627846
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020279163642627846
TRISOMY 13	0.000541419	0.020279163642627846
LUJO HEMORRHAGIC FEVER	0.000541419	0.020279163642627846
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020279163642627846
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.020279163642627846
DDOST-CDG	0.000541419	0.020279163642627846
RAMON SYNDROME	0.000541419	0.020279163642627846
ISOLATED BILIARY ATRESIA	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020279163642627846
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020279163642627846
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020279163642627846
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020279163642627846
NOCARDIOSIS	0.000541419	0.020279163642627846
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.020279163642627846
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020279163642627846
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020279163642627846
THYROCEREBRORENAL SYNDROME	0.000541419	0.020279163642627846
RIFT VALLEY FEVER	0.000541419	0.020279163642627846
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020279163642627846
STURGE-WEBER SYNDROME	0.000541419	0.020279163642627846
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020279163642627846
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020279163642627846
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020279163642627846
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020279163642627846
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020279163642627846
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020279163642627846
TAKAYASU ARTERITIS	0.000541419	0.020279163642627846
MERCURY POISONING	0.000541419	0.020279163642627846
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020279163642627846
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020279163642627846
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020279163642627846
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020279163642627846
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020279163642627846
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020279163642627846
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020279163642627846
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020279163642627846
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.020279163642627846
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020279163642627846
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020279163642627846
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020279163642627846
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020279163642627846
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020279163642627846
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020279163642627846
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020279163642627846
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020279163642627846
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020279163642627846
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020279163642627846
ATAXIA-TELANGIECTASIA	0.000541419	0.020279163642627846
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020279163642627846
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020279163642627846
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.020279163642627846
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020279163642627846
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020279163642627846
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020279163642627846
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020279163642627846
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020279163642627846
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020279163642627846
TENORIO SYNDROME; TNORS	0.000541419	0.020279163642627846
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020279163642627846
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020279163642627846
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020279163642627846
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020279163642627846
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020279163642627846
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020279163642627846
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020279163642627846
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020279163642627846
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.020279163642627846
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020279163642627846
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020279163642627846
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.020279163642627846
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020279163642627846
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020279163642627846
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020279163642627846
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020279163642627846
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.020279163642627846
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020279163642627846
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020279163642627846
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020279163642627846
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020279163642627846
CRYPTOCOCCOSIS	0.000541419	0.020279163642627846
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020279163642627846
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020279163642627846
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020279163642627846
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020279163642627846
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020279163642627846
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020279163642627846
2Q24 MICRODELETION SYNDROME	0.000541419	0.020279163642627846
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020279163642627846
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020279163642627846
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020279163642627846
DISTAL TRISOMY 15Q	0.000541419	0.020279163642627846
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020279163642627846
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020279163642627846
FAMILIAL DYSAUTONOMIA	0.000541419	0.020279163642627846
DYSEQUILIBRIUM SYNDROME	0.000541419	0.020279163642627846
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020279163642627846
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020279163642627846
COCKAYNE SYNDROME	0.000541419	0.020279163642627846
FRONTAL ENCEPHALOCELE	0.000541419	0.020279163642627846
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020279163642627846
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020279163642627846
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020279163642627846
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020279163642627846
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020279163642627846
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.020279163642627846
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.020279163642627846
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020279163642627846
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020279163642627846
CRISPONI SYNDROME	0.000541419	0.020279163642627846
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020279163642627846
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020279163642627846
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020279163642627846
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020279163642627846
ROMANO-WARD SYNDROME	0.000541419	0.020279163642627846
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020279163642627846
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020279163642627846
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020279163642627846
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020279163642627846
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020279163642627846
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020279163642627846
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020279163642627846
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020279163642627846
BETA-MANNOSIDOSIS	0.000541419	0.020279163642627846
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020279163642627846
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020279163642627846
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020279163642627846
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020279163642627846
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020279163642627846
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020279163642627846
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020279163642627846
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020279163642627846
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020279163642627846
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020279163642627846
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020279163642627846
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020279163642627846
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020279163642627846
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020279163642627846
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020279163642627846
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.000541419	0.020279163642627846
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020279163642627846
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020279163642627846
